I am a moderate to aggressive investor.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
3D Signatures Announces Intention to File for Bankruptcy
TORONTO, May 31, 2018 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), a personalized medicine company with a proprietary software platform (TeloViewTM) based on the three-dimensional analysis of chromosomal signatures, today announced its intention to assign itself into bankruptcy under the Bankruptcy and Insolvency Act (the “BIA”) and the layoff of its employees and contractors.
As a research and development stage company, 3DS is primarily dependent on funding from investors to continue as a going concern. While 3DS has been successful in reducing its overall cost structure, it has been unable to secure the additional financing required to fund its operations. As a result, the Company intends to assign itself into bankruptcy under the BIA. In addition, the Company has conducted a layoff of its employees and contractors. Subsequent to the filing of the assignment into bankruptcy, the Licensed Insolvency Trustee may request certain key employees to provide assistance with its administration. The Board of Directors of 3DS has not resigned and will cooperate fully with the Licensed Insolvency Trustee once they are retained in accordance with the resolution passed by the Board of Directors on May 30, 2018.
Third Quarter Financial Summary
The Company significantly reduced its cash monthly burn rate and recorded a net loss of $920,758 ($0.01 per Common Share) for the three months ended March 31, 2018 compared to $2,171,822 ($0.04 per Common Share) for the three months ended March 31, 2017.
As at March 31, 2018, the Company had cash resources of $618,411 compared to $1,200,395 as at June 30, 2017 and $2,552,822 at March 31, 2017. As at March 31, 2018 the Company had working capital of $390,689 compared to working capital of $1,329,408 as at June 30, 2017 and $3,215,197 at March 31, 2017.
The Company’s financial statements and management’s discussion and analysis are available on www.sedar.com.
About 3DS
3DS (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) is a personalized medicine company with a proprietary software platform, TeloView™, that is designed to predict the course of certain diseases and to tailor treatment options for the individual patient. The technology is based on the three-dimensional analysis of telomeres, the protective caps at the ends of chromosomes. 3DS’ TeloView™ software platform measures the organization of the genome and its correspondence to; the stage of a given disease, the rate of progression of the disease, how different diseases will respond to various therapies, and a drug’s efficacy and toxicity. 3DS’ proprietary imaging software is designed to go beyond identifying whether a patient suffers from a specific disease or condition. Instead, the TeloViewTM platform is designed to inform clinicians and patients with respect to how to personalize treatment and best manage an individual’s disease based on their unique TeloView ScoreTM.
For more information, visit the Company’s website at: http://www.3dsignatures.com.
For further information, please contact:
Jason Flowerday
CEO & Director
416-673-8487
investors@3dsignatures.com
Cautionary Note Regarding Forward-Looking Statements
This news release contains forward-looking statements which constitute “forward-looking information” within the meaning of applicable Canadian securities legislation (“Forward Looking Statements”). All statements included herein, other than statements of historical fact, are Forward-Looking Statements and are subject to a variety of known and unknown risks and uncertainties which could cause actual events or results to differ materially from those reflected in the Forward-Looking Statements. Often, but not always, these Forward-Looking Statements can be identified by the use of words such as “intends”, “expects” "estimates", "potential", "open", "future", "assumes", "projects", “anticipates”, “believes”, “may”, “continues”, "plans", "will", "to be", or statements that events "could" or "should" occur or be achieved, and similar expressions, including negative variations. Statements with respect to 3DS’ intention to file an assignment under the BIA, the expectation that the CEO and CFO will continue with the Company to assist with the bankruptcy proceedings, among others, are Forward-Looking statements.
Such Forward-Looking Statements reflect the Company’s current views with respect to future events, are subject to risks and uncertainties and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by 3DS as of the date of such statements, are inherently subject to significant medical, scientific, business, economic, competitive, political and social uncertainties and contingencies. Many risk factors could cause the Company’s actual results, performance, achievements, prospects or opportunities to be materially different from any future results, performance or achievements that may be expressed or implied by such Forward-Looking Statements, including risks related to the filing of an assignment under the BIA by the Company, the expectation that the CEO and CFO will continue with the Company to assist with the bankruptcy proceedings, and the timing of the bankruptcy proceedings, as well as those risks discussed under the heading "Risk Factors" in the Company's annual management’s discussion and analysis dated October 23, 2017 and filed on SEDAR. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in the Forward-Looking Statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended.
In making the Forward-Looking Statements, the Company has made various material assumptions including, but not limited to, 3DS’ ability to complete the assignment under the BIA in a timely and orderly fashion.
3DS believes that the assumptions and expectations reflected in the Forward-Looking Statements in this press release are reasonable, but no assurance can be given that these expectations will prove to be correct. Forward-Looking Statements should not be unduly relied upon. This information speaks only as of the date of this press release, and 3DS will not necessarily update this information, unless required to do so by securities laws.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Zinc Plus Advanced Technology Equals Beneficiary Pistol BayMATT CRAZE | MAY 22, 2018 | NO COMMENTS
https://bit.ly/2IZc0QU
A well-versed theme in these columns is how technology has created a paradigm shift in mining exploration. Not only are mining companies now better equipped to survey historic mining sites on a smaller budget, but many of the metals they are looking for have underperformed in recent decades.Take zinc. The zinc market of all of the London Metal Exchange (LME) traded metals is the contract with the lousiest supply and demand fundamentals. Somewhat akin to the shipping industry in recent years, the industry built a swathe of new mines in the 1980s and 1990s, flooding the market for decades.
Only in recent years have some of those mines, such as the massive Century mine in Australia, became exhausted and created a more favourable price environment for zinc miners.
Although top producer Glencore aided the most recent price run by shutting down two mines in Australia, restarting them is unlikely to close a supply gap, heralding an era of promising economics for developers of new deposits. Charles Desjardins, the founder of Pistol Bay Mining Inc. (TSXV: PST), looked for a metal that could surprise on the upside in coming years, but has suffered from a dearth in exploration activity.
“The reason I got into zinc 3-4 years ago when prices were crappy, I was looking for where there might be a commodity shock, and zinc looked like a good prospect,” Desjardins said.
Pistol Bay bought a claim in Confederation Lake, Western Ontario where historical drilling in an area of volcanogenic massive sulphide ore (VMS) showed mineralization that would be attractive to mine in current market conditions. Being an area of zinc (of little interest to geologists since the 1970s), Desjardins was able to secure an area of 20,700 hectares (51,050 acres). With a 5% zinc equivalent cut-off, the Garnet Lake or Arrow Zone area holds an indicated resource of 2.1 million tons averaging 5.78% zinc, 0.72% copper, 0.60 g/t of gold and 19.5 g/t of silver (that’s 8.42% zinc equivalent.
Desjardins said another zinc project being developed currently by Calinex Mines Ltd. in New Brunswick gives an internal rate of return (IRR) estimate of 34% on a project with a 4.2% zinc equivalent, giving him optimism that the economics of his project are promising.
{GET OUR DAILY INVESTORINTEL UPDATE
Your Email
Subscribe
}
A procession of companies explored the site in the 1970s, but airborne electromagnetic surveying has greatly evolved since then. Currently technology allows companies to detect anomalies as deep as 700 meters. One geologist of former mining company Noranda who worked at the Confederation Lake site told Desjardins recently that back in the 1970s, this type of surveying could only yield results until 200 meters depth.
Those studies were conducted when there was a looming global zinc shortage. The market scenario, like so many mining boom-to-bust cycles, prompted several major mining companies to develop zinc mines during that period. That geological work led to the discovery of the massive Red Dog mine in Alaska that started up in the late 1980s. The Century mine in northern Australia started in 1999, and accounted for up to 5% of global output until its closure in 2016.
The timely sale of a uranium deposit to mining giant Rio Tinto Plc funded Pistol Bay with $1.5 million this year to start drilling at the Arrow Zone. Results are due later this month. Pistol Bay also plans to drill the Fridart site in the Confederation Lake, that unlike all other targets contains high quantities of copper.
The airborne surveys and advanced downhole technology is giving Pistol Bay plenty of clues of where to drill next at the company’s concessions, which span 60 kilometers in length by 25 kilometers in width. Pistol Bay may form alliances with other exploration companies to advance work at other sites.“This technology is giving us a whole new bunch of things to chase,” Desjardins said. “We are going to be a busy group.
”GOLD, SILVER & BASE METALS INTEL
3D Signatures Inc. Announces Successful Scoring Model Development and Analytical Validation of the Telo-HL(TM) Test for Hodgkin ’s Lymphoma
TORONTO, April 03, 2018 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), a personalized medicine company with a proprietary software platform (TeloViewTM) based on the three-dimensional analysis of chromosomal signatures, is pleased to announce the successful and on-time development of the scoring model for Telo-HLTM, the Company’s lead test for Hodgkin’s lymphoma (“HL”), as well as completion of an analytical validation study to confirm the reproducibility of its Telo-HLTM test.
Powered by the Company’s proprietary TeloViewTM platform, Telo-HLTM is a predictive test performed on diagnostic lymph node biopsy specimens, intended to provide clinicians with the first biomarker capable of identifying the 15% - 20% of HL patients who will fail standard ABVD chemotherapy, and who should immediately be considered for more advanced treatment or inclusion into clinical trials with an emerging immunotherapy.
The study data from the Company’s multi-parametric telomeric analysis with TeloViewTM was analyzed by an independent statistical provider, BioStat Solutions Inc. (“BSSI”), to develop the Telo-HLTM scoring model from over 200 potential predictors that included different combinations of the telomeric nuclear organization, cell type, and clinical parameters. BSSI identified that a combination of at least three of the parameters analyzed by TeloViewTM contributed to the scoring model with highly predictive characteristics. This included measures unique to 3DS’s platform, which can only be evaluated through three-dimensional analysis of telomeres, and for which current clinical data alone is insufficient to predict risk of relapse.
In addition, the Company reports it has successfully run an internal analytical validation of the test by processing and analyzing, in triplicate, archived samples from the same patients. This important step demonstrates the consistency of the Telo-HLTM test and reproducibility of TeloViewTM results under a variety of conditions.
“In keeping with best practices, external scientific peer-review is now essential to confirm our own evaluation of Telo-HLTM’s strong performance and reproducibility,” notes Dr. Kevin Little, CSO of 3DS. “The detailed findings will be submitted as quickly as possible for presentation in clinician meetings, and then publication in a top-level clinical journal in the latter half of 2018. This will build awareness with key opinion leaders and pharmaceutical companies that Telo-HLTM is ready and available to be incorporated into clinical trials as a correlative biomarker alongside new therapeutic interventions.”
“This is the most significant accomplishment for the Company yet, and I congratulate everyone involved for achieving this critical milestone as per our plan,” commented Jason Flowerday, CEO of 3DS. “This highly successful study is an important culmination of the work by Dr. Sabine Mai and the 3DS team, to develop the first clinically-compliant and validated test based on telomeric profiling, which can uniquely inform treatment decisions in Hodgkin’s lymphoma. Telo-HLTM represents a critical proof-of-principle for the Company’s TeloViewTM platform that we believe may establish an entirely new clinical paradigm for genome organization, and accelerate the development of our broader platform of TeloViewTM-based tests in prostate cancer, lung cancer and multiple myeloma.”
About 3DS
3DS (TSX-V:DXD; OTCQB:TDSGF; FSE:3D0) is a personalized medicine company with a proprietary software platform, TeloView™, that is designed to predict the course of certain diseases and to tailor treatment options for the individual patient. The technology is based on the three-dimensional analysis of telomeres, the protective caps at the ends of chromosomes. 3DS’ TeloView™ software platform measures the organization of the genome and its correspondence to; the stage of a given disease, the rate of progression of the disease, how different diseases will respond to various therapies, and a drug’s efficacy and toxicity. 3DS’ proprietary imaging software is designed to go beyond identifying whether a patient suffers from a specific disease or condition. Instead, the TeloViewTM platform is designed to inform clinicians and patients with respect to how to personalize treatment and best manage an individual’s disease based on their unique TeloView ScoreTM. As healthcare moves increasingly toward better informed, patient-centric approaches, the Company intends for the TeloViewTM platform to deliver personalized medicine that allows for better treatments, leading to better outcomes.
The TeloViewTM platform is supported by 25 clinical studies involving more than 3,000 patients and 20 different cancers, plus Alzheimer’s disease. 3DS benefits from twenty years of research, $25M of non-dilutive investment into its platform and more than 130 supporting publications, and holds a portfolio of patents related to three-dimensional telomere analysis for proliferative diseases, including (but not limited to) hematological disorders such as Hodgkin's lymphoma, multiple myeloma, and chronic myeloid leukemia. 3DS’ intellectual property portfolio also covers prostate cancer, breast cancer, lung cancer, melanoma, colorectal cancer, and Alzheimer’s disease.
For more information, visit the Company’s website at: http://www.3dsignatures.com.
For further information, please contact:
Jason Flowerday
CEO & Director
416-673-8487
investors@3dsignatures.com
Wealth Enters Strategic Alliance with the National Mining Company of Chile - ENAMI
VANCOUVER, British Columbia, March 19, 2018 (GLOBE NEWSWIRE) -- Wealth Minerals Ltd. (the “Company” or “Wealth”) - (TSXV:WML) (OTCQB:WMLLF) (SSE:WMLCL) (Frankfurt:EJZN) announces that it has entered into an agreement (the “Agreement”) with the fully state-owned National Mining Company of Chile (“ENAMI”), whereby the parties have agreed to form a strategic alliance to develop and commercialize the Company’s projects in the Salar de Atacama and Laguna Verde. The Agreement provides that the parties will have 24 months during which to study and assess the aforementioned properties and to form a partnership (the “JV”) for the exploration, development and mining thereof and for the marketing of the products from the projects. The Agreement contemplates that the JV will take the form of an incorporated joint venture company in which ENAMI will own 10% of the JV and have a 10% free-carried interest, while Wealth will own the remaining 90% of the JV. The Agreement provides that the parties will have 24 months to enter into a definitive agreement that will govern the formation and operation of the JV.
Hendrik van Alphen, Wealth’s CEO, stated “We are very happy to have ENAMI as a partner for developing our assets. Not only are we now able to draw upon ENAMI’s experience and knowledge for successfully mining and processing resources in Chile, we have gained a strong state partner that can help fulfill our goals of full scale development to achieve production of lithium and by-products in Chile. This will enable Wealth and ENAMI to meet the world’s growing demand for lithium and secure Chile’s position as a premier player in global lithium markets.”
Background
Under current Chilean law, and since January 1, 1979, lithium cannot be exploited in Chile by regular mining concessions. The Chilean Mining Code establishes that lithium is a strategic mineral and expressly provides that the exploitation of “non-concessible” mineral substances (which includes lithium) can only be performed by:
the Government of the Republic of Chile,
a Chilean state-owned company, or
by means of administrative concessions or special operation contracts that meet the requirements and conditions set forth by the President of the Republic of Chile for each such case.
While a few active licenses in Chile were granted before the current state regulations came into force, the lithium production associated with these licenses represents a small portion of the anticipated lithium supply. The Agreement provides Wealth, along with ENAMI, the ability to apply for the grant of the permits required to explore, develop, produce and export lithium in accordance with the terms of export quotas, in effect from time to time.
Lithium Mining Industry in Chile
Chile is the world’s second largest lithium producer and the largest producer of lithium extracted from high-quality and high-concentration brines, accounting for approximately 35% of the total global production representing 75,800t of lithium carbonate equivalent. Despite this significant footprint in the industry, lithium production in Chile comes exclusively from two operations in a claim owned by CORFO in the Atacama Salar. CORFO (Production Development Corporation), a government body responsible for regional development, has contracted production services to both Albemarle and Sociedad Química y Minera de Chile S.A. or “SQM”. Neither Albemarle nor SQM own the licenses through which they extract lithium, as both companies contract directly with CORFO and not the Chilean state1. As such, all contracts governing the relationship between CORFO, Albemarle and SQM are specific to their operations in the Atacama Salar and are not representative of the current regulatory regime governing the exploitation of resources from lithium licenses generally. In the past year, other companies have begun to enter the lithium space in Chile, most notably CODELCO (National Copper Corporation), Wealth and Lithium Power International, with projects in preliminary stages of development. Chile’s new President, Mr. Sebastián Piñera, and the incoming Minister of Mines, Mr. Baldo Prokurica, have publicly stated their support for Chile’s mining industry and their political platform of attracting foreign and domestic investment to Chile’s natural resource sector.
About ENAMI
ENAMI was established in the 1960s as a state company tasked with promoting the Chilean mining industry, by buying and processing the production of small and medium sized national mining companies. ENAMI is one of two state-owned companies in Chile involved in the mining industry, the other one being CODELCO.
About Wealth Minerals Ltd.
Wealth is a mineral resource company with interests in Canada, Mexico, Peru and Chile. The Company’s main focus is the acquisition of lithium projects in South America. To date, the Company has positioned itself to develop the Aguas Calientes Norte and Quisquiro Salars in Chile (the Trinity Project), as well as to work alongside existing producers in the prolific Atacama Salar. In addition to the Laguna Verde lithium project acquisition, the Company has also positioned itself to play a role in asset consolidation in Chile with the Five Salars project.
The Company is transitioning from asset acquisition to the development of its current high potential portfolio and, in connection therewith, has already invested more than a year on community engagement and geo-physics work related to its Chilean projects. Lithium market dynamics and a rapidly increasing metal price are the result of profound structural issues within the industry meeting anticipated future demand. Wealth is positioning itself to be a major beneficiary of this future mismatch of supply and demand. The Company also maintains and continues to evaluate a portfolio of precious and base metal exploration-stage projects.
For further details on the Company readers are referred to the Company’s website (www.wealthminerals.com) and its Canadian regulatory filings on SEDAR at www.sedar.com.
On Behalf of the Board of Directors of
WEALTH MINERALS LTD.
“Hendrik van Alphen”
Hendrik van Alphen
Chief Executive Officer
For further information, please contact: Marla Ritchie
Phone: 604-331-0096 Ext. 3886 or 604-638-3886
E-mail: info@wealthminerals.com
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
Cautionary Note Regarding Forward-Looking Statements
This news release contains forward-looking statements and forward-looking information (collectively, “forward-looking statements”) within the meaning of applicable Canadian and U.S. securities legislation, including the United States Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, included herein including, without limitation, the Company’s expectation that it will be able to enter into a definitive JV agreement with ENAMI, anticipated exploration program results from exploration activities, the Company’s expectation that it will be able to obtain the necessary permits to exploit, develop, produce and export lithium, and the anticipated business plans and timing of future activities of the Company, are forward-looking statements. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. Forward-looking statements are typically identified by words such as: “believe”, “expect”, “anticipate”, “intend”, “estimate”, “postulate” and similar expressions, or are those, which, by their nature, refer to future events. In making the forward-looking statements in this news release, the Company has applied several material assumptions, including without limitation, that market fundamentals will result in sustained lithium demand and prices, the receipt of any necessary permits, licenses and regulatory approvals in connection with the future development of the Company’s Chilean lithium projects in a timely manner, the availability of financing on suitable terms for the development, construction and continued operation of the Company projects, and the Company’s ability to comply with environmental, health and safety laws.
Forward-looking statements by the Company are not guarantees of future results or performance, and actual results may differ materially from those in forward-looking statements as a result of risks and other various factors, including, operating and technical difficulties in connection with mineral exploration and development activities, actual results of exploration activities, the estimation or realization of mineral reserves and mineral resources, the timing and amount of estimated future production, the costs of production, capital expenditures, the costs and timing of the development of new deposits, requirements for additional capital, future prices of lithium, changes in general economic conditions, changes in the financial markets and in the demand and market price for commodities, accidents, labour disputes and other risks of the mining industry, delays in obtaining governmental approvals, permits or financing or in the completion of development or construction activities, changes in laws, regulations and policies affecting mining operations, title disputes, the inability of the Company to obtain any necessary permits, consents, approvals or authorizations (including acceptance by the TSX Venture Exchange) required for the definitive JV agreement, the timing and possible outcome of any pending litigation, environmental issues and liabilities, risks related to joint venture operations, and other risks and uncertainties disclosed in the Company’s latest interim Management’s Discussion and Analysis and filed with certain securities commissions in Canada. All of the Company’s Canadian public disclosure filings may be accessed via www.sedar.com and readers are urged to review these materials, including the technical reports filed with respect to the Company’s mineral properties.
Readers are cautioned not to place undue reliance on forward-looking statements. The Company undertakes no obligation to update any of the forward-looking statements in this news release or incorporated by reference herein, except as otherwise required by law.
1 CORFO is a government agency and not a state-owned company such as ENAMI or CODELCO.
Wealth Minerals halted at 10:21 a.m. PT
Wealth Minerals Ltd (2) (C:WML) (OTC:WMLLF)
Shares Issued 107,327,066
Last Close 3/15/2018 $1.83
Friday March 16 2018 - Halt Trading
Wealth Minerals Ltd. has been halted at 10:21 a.m. PT on March 16, 2018, at the request of the company, pending news.
© 2018 Canjex Publishing Ltd.
PISTOL BAY TO START DRILLING AT CONFEDERATION LAKE IN MARCH 2018
Vancouver, B.C. – February 22, 2018: Pistol Bay Mining Inc. (TSX-V - PST; OTC-SLTFF; Frankfurt - OQS2) (“Pistol Bay” or the “Company’) is pleased to announce that it is currently soliciting and reviewing bids from drilling contractors for the rights to drill the Company’s Confederation Lake greenstone belt VMS properties. A decision is expected shortly, and drilling is planned to commence March 2018.
Pistol Bay has received the one million dollars ($1,000,000) from Rio Tinto for the uranium assets it owned in the Athabasca Basin (see news release February13,2018). Proceeds from this payment will be used to fund the drilling program at Confederation Lake.
Three drill holes of at least 500 metres each are planned to further test the Arrow Zone and to retrieve core for preliminary metallurgical testing. The Arrow Zone was the subject of a 43-101 report in 2017 that presented an inferred mineral resource of 2,100,000 tonnes grading 5.78% zinc, 0.72% copper, 0.60 grams per tonne (g/t) gold and 19.5 g/t silver. (8.42% zinc eq.) (see news release February 15, 2018).
Approximately ten diamond drill holes totaling approximately 2,000 metres will test the Fredart “A” Zone (also referred to as the Copperlode “A” Zone). A historical resource estimate made in 1971 for the Fredart “A” Zone, based on diamond drilling in the 1960s, was 386,000 tonnes grading 1.56% copper and 33.6 g/t silver, or alternatively 219,500 tonnes at 1.95% copper and 41.8 g/t silver. Neither of these estimates conforms to any class of mineral resource or mineral reserve defined by the 2014 CIM guidelines.
About Pistol Bay Mining Inc. Pistol Bay Mining Inc. is a diversified Junior Canadian Mineral Exploration Company with a focus on zinc and base metal properties in North America. The company has also created a subsidiary for resource driven blockchain applications. For additional information please visit the Company website at www.pistolbaymininginc.com or contact Charles Desjardins at pistolbaymining@gmail.com.
On Behalf of the Board of Directors PISTOL BAY MINING INC.
"Charles Desjardins" Charles Desjardins, President and Director
PISTOL BAY PLANS 2018 DRILLING PROGRAM IN CONFEDERATION LAKE
Vancouver, B.C. – February 15, 2018: Pistol Bay Mining Inc. (TSX-V - PST; OTC-SLTFF; Frankfurt - OQS2) (“Pistol Bay” or the “Company’) is pleased to announce that it plans to commence a 2018 drilling program on it’s Confederation Lake greenstone belt in the very near future.
Charles Desjardins, President and CEO of Pistol Bay, commented, “After the company’s very encouraging VTEM plus survey in 2017, we are excited to commence the next stage of development of Confederation Lake volcanic massive sulphide belt.”
Three drill holes of at least 500 metres each are planned to further test the Arrow Zone, and to retrieve core for preliminary metallurgical testing. The Arrow Zone was the subject of a 43-101 report in 2017 that presented an inferred mineral resource of 2,100,000 tonnes grading 5.78% zinc, 0.72% copper, 0.60 grams per tonne (g/t) gold and 19.5 g/t silver. (8.42% zinc eq.)
Additionally, the Company plans to survey the older drill holes on the Arrow Zone, which were drilled by Noranda in 1997 and 1998, using a gyro or similar method, to accurately determine hole deviation. Collars of all holes on the Arrow zone will be surveyed by differential GPS to determine their precise location and the initial azimuth. These new and precise measurements will allow more precise positioning of drill intercepts and will ultimately lead to a higher level of confidence in the mineral resource.
Approximately 10 diamond drill holes totaling approximately 2,000 metres will test the Fredart “A” zone (also referred to as the Copperlode “A” zone). A historical resource estimate made in 1971 for the Fredart “A” zone, based on diamond drilling in the 1960s, was 386,000 tonnes grading 1.56% copper and 33.6 g/t silver, or alternatively 219,500 tonnes at 1.95% copper and 41.8 g/t silver. Neither of these estimates conforms to any class of mineral resource or mineral reserve defined by the 2014 CIM guidelines.
Although the first five holes in 1965 were assayed for gold with results up to 1.2 g/t Au, the remaining 76 holes were not assayed for gold. Four of the highest grade and widest drill intercepts on the Fredart “A” zone were:
DDH 65-03: 1.83 metres @ 5.24% Cu and 170.45 g/t Ag DDH 66-11: 6.61 metres @ 3.37% Cu and 159.52 g/t Ag DDH 66-15: 17.53 metres @ 2.54% Cu and 45.72 g/t Ag DDH 66-18: 46.21 metres @ 1.18% Cu and 51.11 g/t Ag
Intersection lengths are core lengths; true widths are not known. Sampling, assaying, security and QC protocols are unknown.
Technical information in this news release was reviewed by Colin Bowdidge, Ph.D., P.Geo., a Qualified Person as defined in National Instrument 43-101
About Pistol Bay Mining Inc.
Pistol Bay Mining Inc. is a diversified Junior Canadian Mineral Exploration Company with a focus on zinc and base metal properties in North America. The company has also created a subsidiary for resource driven blockchain applications. For additional information please visit the Company website at www.pistolbaymininginc.com or contact Charles Desjardins at pistolbaymining@gmail.com.
On Behalf of the Board of Directors PISTOL BAY MINING INC.
"Charles Desjardins" Charles Desjardins, President and Director
RIO TINTO EXERCISES OPTION FOR PISTOL BAY C-BLOCK URANIUM PROPERTIES
Vancouver, BC – February 13, 2018: Pistol Bay Mining Inc. (TSX-V: PST) (Frankfurt – OQS2)(OTC-SLTFF) (“Pistol Bay” or the “Company”) is pleased to report that the Company has entered into an amending and final agreement with Rio Tinto Canada Uranium Corp. (”RTCUC” or “Rio Tinto”), with regard to the C 4, 5 and 6 Uranium properties, whereby Rio Tinto will make a final cash payment of $1,000,000 to Pistol Bay.
The C block of Uranium properties, located in the Athabasca Basin of Saskatchewan, is under option to Rio Tinto, which has earned a 75-per-cent interest to date.
Under the 4th amending and final agreement, Rio Tinto will acquire an additional 25% interest in the Property (thereby increasing its aggregate interest to 100%), by making a cash payment of $1,000,000 to Pistol Bay within 14 days from the effective date of this final agreement. As part of this final agreement, no royalty is granted to Pistol Bay with respect to the property under the agreement.
About Pistol Bay Mining Inc.
Pistol Bay Mining Inc. is a diversified Junior Canadian Mineral Exploration Company with a focus on zinc and base metal properties in North America. The company has also created a subsidiary for resource driven blockchain applications. For additional information please visit the Company website at www.pistolbaymininginc.com or contact Charles Desjardins at pistolbaymining@gmail.com.
On Behalf of the Board of Directors
PISTOL BAY MINING INC.
"Charles Desjardins" Charles Desjardins, President and Directo
PB Blockchain Announces “HashDrop” Blockchain Application
Vancouver, B.C. – January 31, 2018: Pistol Bay Mining Inc. (TSX-V - PST; OTC-SLTFF; Frankfurt- OQS2) (“Pistol Bay” or the “Company’) is pleased to give an update on the development of our subsidiary, PB Blockchain Inc. (see news release dated November 15, 2017.) This wholly owned subsidiary is focused on blockchain applications for mining and resource company management. We will be leveraging the work of other Application Program Interface (API) companies to build a suite of blockchain products to address needs that are particular to the data management and security of mining/oil and gas companies. It is expected that many of these blockchain products could have crossover to other industries.
Charles Desjardins, President and CEO of PB Blockchain, is pleased to report that our development team is creating our own application named “HashDrop”. This will be accomplished by utilizing existing blockchain solutions to create a secure platform for parties to manage and update digital assets and documents within their data centers while providing trusted transactions with full confidence in the principle of the information being shared or accessed.
It is a secure, comprehensive, and unalterable platform that eliminates the time and costs of document sharing and assembly. It enables the organization to better coordinate compliances, deliver information efficiently, and trade digital assets securely. With a wide range of device types, our platform adapts to various device configurations.
Our easy to use interfaces are backed by the infrastructure behind the scenes to ensure fast, reliable uploads, downloads, and sharing. Our team who is creating HashDrop will continue to evolve the product and architecture to ensure speed data transfer and improved reliability.
The framework of our HashDrop application will be as follows:
A. Architecture Designed with multiple levels of protection covering: • Data transfer • Encryption • Network configuration • Application-level controls all distributed across a scalable, secure infrastructure
B. Platform Objectives • A secure platform for users or parties to manage and update digital assets and documents • Integrate with Ethereum blockchain for logging all digital assets, data, and documents • Validate and allow transfer of ownership of the digital assets
C. Authentication • Different levels of authority access • Login/register using email and password
D. Accessibility • Parties can share and manage digital assets anywhere with internet access - with the utilization of public blockchain, information is shared under a fast and secure environment
E. Search Function • Authorized members are able to search for all data & digital assets that are uploaded on to the blockchain platform through our user-friendly interface • Our HashDrop application will communicate with the secured database that is synced with the blockchain, where uploaded data & digital assets are recorded
F. Quality Control • Documentation errors are the No.1 source of defects and generate excessive costs and time • Our platform eliminates duplicate documents, lost documents, document issues, and exceptions
G. Due Diligence • Whether it is file transfer or trade of digital assets, the costs will be significantly reduced to all parties to review and audit the documents and data associated with the transaction
H. Sharing Permissions Administration will have comprehensive control of: • The team sharing abilities • Whether members can share files and folders with people within the company • Whether members can edit folders owned by people within the company • Whether members can create file request and collect files from other members of the company • Whether members can view and make comments on files
About Pistol Bay Mining Inc. Pistol Bay Mining Inc. is a diversified Junior Canadian Mineral Exploration Company with a focus on zinc and base metal properties in North America. The company has also created a subsidiary for resource driven blockchain applications. For additional information please visit the Company website at www.pistolbaymininginc.com or contact Charles Desjardins at pistolbaymining@gmail.com.
On Behalf of the Board of Directors PISTOL BAY MINING INC.
"Charles Desjardins" Charles Desjardins, President and Director
PISTOL BAY ACQUIRES ADDITIONAL ZINC-COPPER PROPERTIES IN CONFEDERATION LAKE VMS GREENSTONE BELT, ONTARIO
Vancouver, B.C. – January 10, 2018: Pistol Bay Mining Inc. (TSX-V - PST; Frankfurt - OQS2) (“Pistol Bay” or the “Company’) is pleased to announce that it has entered into an option agreement with an arm’s length vendor to acquire a 100% interest in the Mitchell, Gerry Lake and Karas Lake Properties, located in the Karas Lake Area, Red Lake Mining Division, Ontario (the “Property”).
The Property consists of 33 mining claims, comprising 232 claim units, and covering approximately 3700 hectares.
Charles Desjardins, President & CEO of Pistol Bay, states, “These newly acquired claims were part of our recent 2017 VTEM PLUS survey. We are very excited about the data and have given these targets a high priority for geophysical modelling.”
The Mitchell Township or Fly-Moth claim group covers a 9 kilometre stretch of the Confederation Lake greenstone belt and extends to within 1.5 km of the former producing South Bay zinc-copper-silver mine. The property was explored by Selco Mining Corp., Placer Dome Inc., Kerr-Addison Mines, St Joseph Explorations Ltd., Minnova Inc./Inmet Mining and Noranda Inc. at various times between 1967 and 1999. Previous exploration has included approximately 90 diamond drill holes.
Historical work has identified numerous zinc-bearing sulphide zones across the Mitchell claims, including the Wasp Lake, Fly Lake, Trippier, Culvert, Moth and Road Zones. Following are a few highlights from previous work.
The Wasp Lake Mineralized Trend was extensively drilled by Selco; most results are unavailable. Two holes by St Joseph Explorations yielded the following:
DDH 3197-6-80: 2.79 m @ 2.96% Zn, 0.04% Cu includes 0.76 m @ 7.44% Zn, 0.05% Cu AND 4.02 m @ 2.18% Zn, 0.01% Cu, 0.26% Pb includes 0.50 m @ 8.97% Zn, 0.02% Cu, 1.17% Pb AND 3.31 m @ 1.27% Zn, 0.09% Cu DDH 3197-7-80: 7.19 m @ 1.12% Zn, 0.04% Cu includes 1.24 m @ 3.63% Zn, 0.14% Cu AND 4.29 m @ 0.98% Zn, 0.01% Cu, 0.15% Pb
This mineralized trend gave a strong conductive response on Pistol Bay’s recent VTEM PLUS airborne survey. The Company plans to have the geophysics modelled to assess the possibility of a deep-seated massive sulphide zone.
The Fly Lake zone was tested by 4 drill holes by St Joseph Minerals in 1976 over a 50 metre length. Pistol Bay’s VTEM PLUS survey gave a well-defined response on 2 lines, indicating a length of up to 400 metres. Results of the St Joseph drilling include:
DDH 3197-2-79: 0.60 m @ 1.71% Zn, 0.15% Cu, 0.3 g/t Ag AND 0.27 m @ 2.00% Zn, 0.08% Cu DDH 3197-1-80: 4.51 m @ 0.53% Zn, 0.06% Cu includes 0.76 m @ 1.34% Zn, 0.18% Cu AND 11.5 m @ 1.36% Zn, 0.17% Cu includes 2.65 m @ 4.30% Zn, 0.21% Cu includes 1.01 m @ 8.25% Zn, 0.34% Cu
DDH 3197-2-80: 0.30 m @ 2.69% Zn, 0.07% Cu AND 4.90 m @ 1.51% Zn, 0.06% Cu AND 0.90 m @ 1.98% Zn, 0.01% Cu DDH 3197-3-80: 8.90 m @ 1.51% Zn, 0.08% Cu includes 3.90 m @ 2.53% Zn, 0.06% Cu includes 1.00 m @ 4.63% Zn, 0.09% Cu
This zone appears to be open along strike and at depth. The Company proposes to drill for extensions of the mineralization, assisted by modelling of the VTEM data.
VTEM Anomalies: There are 9 discrete VTEM PLUS conductive anomalies that do not appear to have had any previous drill testing. Their conductivity varies from very weak to moderate. Most are in areas with little or no outcrop and one is under a lake.
The Transaction
The Company can earn a 100% interest in the Property by issuing an aggregate 500,000 common shares and paying a total of $104,000 over a four-year period. A 1.5% NSR has been granted to the vendor, of which 0.75% may be purchased at any time by the Company for $400,000.
This transaction is subject to TSX Venture Exchange approval. All shares issued will be subject to a hold period expiring four months and one day from the day of issuance.
Technical information in this news release has been provided and/or reviewed by Colin Bowdidge, Ph.D., P.Geo., a Qualified Person as defined in National Instrument 43-101.
About Pistol Bay Mining Inc.
Pistol Bay Mining Inc. is a diversified Junior Canadian Mineral Exploration Company with a focus on zinc and base metal properties in North America. For additional information please visit the Company website at www.pistolbaymininginc.com or contact Charles Desjardins at pistolbaymining@gmail.com.
On Behalf of the Board of Directors PISTOL BAY MINING INC.
"Charles Desjardins" Charles Desjardins, President and Director
President’s Message to Pistol Bay Shareholders
January 4, 2018
On behalf of the Directors and myself, we would like to thank all our loyal shareholders for your support in 2017 and look forward to your continued support in 2018 and beyond.
As we move forward in 2018, which we feel will be a very exciting time in the company’s history, I would like to reflect upon our activities and accomplishments in 2017.
Confederation Lake (Zinc, Copper, Silver, Gold VMS Greenstone Belt)
The year started off with the company receiving exchange approval to proceed with acquiring the AurCrest properties in the Confederation Lake greenstone belt. These properties expanded our holdings in Confederation Lake making us the dominant landholder in this VMS-rich greenstone belt. With this land package, plus the previous land holdings, Pistol Bay made plans to do a VTEM PlusTM survey over a large portion of our claims. This geophysical survey was commissioned to test depths of up to 700 metres in areas that were previously tested to only to a depth of 200 metres.
In February, Jody Dahrouge, B.Sc., Sp.C., P.Geol., was added to our Advisory Board. Mr. Dahrouge has been involved in all aspects of mineral exploration and development for a wide variety of commodities worldwide. He is President of Dahrouge Geological Consulting Ltd., a geological services company that provides consulting services to a broad range of public and private exploration and mining companies.
In February and March, Pistol Bay acquired additional land holdings in Confederation Lake that included all historic data, which was reviewed by Colin Bowdidge, Ph.D., P.Geo., and his team. We also closed a private placement financing and received a cash infusion of $750,000 from Rio Tinto exercising part of their option for our Athabascan Basin uranium property (C4, C5, C6 Blocks).
In April, we started the VTEM PlusTM survey which showed fantastic results in identifying numerous new conductors and IP-effect anomalies throughout our land holdings and confirming that many deposits that were already indicated in the historic data acquired in February had potential for tonnage growth. These results were supplied to us by Geotech in September after carefully analyzing and compiling a 3D module model of the data. As a result of all our acquisitions, we now have a total of 297 claim units bringing Pistol Bay’s total land package in the Confederation Lake greenstone belt to over 42,000 acres.
Pistol Bay was invited by the Province of Ontario to be part of their delegation at the Mines and Money Conference in London, England held in November 2017. This conference provided many leads which the company is currently in discussions with. With the data in hand from the VTEM PlusTM survey, we had several Joint Ventures (JV’s) discussions with companies wanting to get involved with the claims Pistol Bay holds in the Confederation Lake area. Some of these JV’s discussions are ongoing and we hope to announce the first joint venture in the very near term.
PB Blockchain Inc (a wholly owned subsidiary of Pistol Bay Mining Inc.)
The company realized early in 2017 that there was a fundamental shift happening in technology, Blockchain! Blockchain and the benefits of distributed ledger was going to impact most industries, if not all, and there is an opportunity to create blockchain products specific to the Mining and Oil and Gas industries.
With this in mind, we created a subsidiary focused on blockchain applications for mining and resource company management. We will be leveraging the work of other Application Program Interface (API) companies to build a suite of blockchain products to address needs that are particular to the data management and security of mining/oil and gas companies. It is expected that many of these blockchain products could have crossover to other industries. These blockchain products may include but will not be limited to focused Ethereum smart contracts, security, claim management, resource management and the tokenization of resources.
In December, PB Blockchain Inc., the wholly owned subsidiary of Pistol Bay, added Brad Moynes to the Advisory Board. Mr Moynes is the founder of DigaTrade Financial Corp (OTCQB: DIGAF), which launched its digital assets exchange on July 1st, 2015. Along with his accomplishments in the Bitcoin early entry into the Cryptocurrency and Blockchain space, Mr Moynes has extensive experience in public company management, finance and corporate relations and has served as a senior executive for a junior mining exploration company.
The technical team is now prioritizing products and working on time lines for roll out of early adopter products. We anticipate several announcements in this regard in January 2018.
The Pistol Bay team would like to wish everyone a Happy and Prosperous New Year!
Charles Desjardins President & CEO Pistol Bay Mining Inc.
Blue Moon Zinc
Can Zinc stay hot in 2018? NAI500 Commentary:
Gilbert Chan February 26, 2018
Zinc leads all the base metals in terms of price rally since midyear last year, why did this happen and can this trend continue in 2018?
Zinc metal market has been in deficit since 2016
The inventory of Zinc continues to be eaten up, with the
supplies look to be down for another year.
Zinc is more or less a “construction & infrastructure” metal, with
the demand increase from China, India and even in USA, it
puts upward pressure on the metal price
Will the Zinc metal price be sustainable in 2018?
The strong global economic recovery looks very likely to continue in 2018, that’s always a good sign for base metals including Zinc
.
Owing in large part to primary mined supply constraints, it will push the refined market balance into an even more substantial deficit position.
No major new Zinc mine productions are in sight
3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HL ™ Test for Hodgkin ’s Lymphoma
TORONTO, Feb. 20, 2018 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS") is pleased to announce that a preliminary third-party analysis of the trial data for Telo-HLTM, 3DS’ test in development for Hodgkin’s lymphoma (HL), shows that the Company’s TeloViewTM platform is able to distinguish, with a high degree of statistical significance, multiple differences between a patient group that responds to standard ABVD chemotherapy, and a group that relapses or is refractory to treatment within the first 12 months.
Telo-HLTM is intended to provide clinicians with the first biomarker to identify the 15% - 20% of new HL patients who will likely fail standard chemotherapy, and who should immediately be considered for more advanced treatment or inclusion into clinical trials to access emerging treatments such as immunotherapies.
3DS has established a clinically-compliant methodology for application of its TeloViewTM process to diagnostic Hodgkin lymphoma biopsy samples, employing more sensitive imaging technology than its previous HL trials. Specimens from over 400 HL patients (who were subsequently treated with ABVD) were processed for this trial, from four contributing hospital sites across Canada and Europe. The 3DS three-step process was applied, comprising a wet lab co-immuno-telomeres FISH assay, 3-dimensional imaging (with identification of 30 Hodgkin and 30 Reed-Sternberg cells), followed by TeloView™ software analysis.
The multi-parametric telomeric analysis with TeloViewTM was performed by 3DS (blinded to patient status), and the results were then shared with statistical partner BioStat Solutions Inc. (“BSSI”), who compared the TeloViewTM data with the corresponding clinical outcomes for patients, and identified highly significant group differences across multiple TeloViewTM parameters.
"BSSI is excited to be collaborating with 3DS, helping them ensure the quality of the data being used is to the highest standards, and that they are poised to deliver the best possible analysis of this predictive technology for HL treatment,” said Ronald L. Bromley, CEO of BioStat Solutions, Inc.
“We believe that these results from the application of our TeloViewTM platform to Hodgkin’s lymphoma are so strong, the Company will now even more confidently proceed with developing the final scoring model for its Telo-HLTM test to predict response at the individual patient level,” said Jason Flowerday, CEO of 3D Signatures. “This is great news for the Telo-HLTM program, and we remain on track to complete all phases of the test development and analytical validation by April 2018.”
The Company intends to submit the completed test development and validation work to a highly reputable clinical journal for publication in the latter half of 2018.
“This trial builds on the foundational work done in Dr. Sabine Mai’s academic laboratory to establish 3D telomere profiling as a novel biomarker platform. We see this as a new genomic stability testing paradigm applicable broadly across clinical trial research and laboratory medicine”, says Dr. Kevin Little, CSO of 3D Signatures.
About Telo-HL™
Powered by 3DS’ proprietary TeloView™ software platform, Telo-HL™ is intended to provide clinicians with the first set of biomarkers that will distinguish between patients that will respond to standard ABVD chemotherapy, and the 15% - 20% of patients who will fail standard chemotherapy and be refractory or relapse within the first year. The Company expects Telo-HL™ to benefit patients seeking personalized treatment and to provide significant cost savings to payors and insurers that are currently burdened with expensive treatments and procedures that may not be necessary if patients could be considered for more targeted and effective therapies at the outset of treatment.
About BSSI
BioStat Solutions, Inc. (BSSI) is a privately held professional service corporation providing statistical and bioinformatics expertise to pharmaceutical and biotech companies as well as to the government and its contractors. BSSI’s diverse team of statisticians, bioinformaticists, epidemiologists and geneticists provides answers to complex and challenging analytical questions. Whether the client is facing big data or machine learning problems, or is looking for new biomarker or diagnostic device strategies, BSSI provides solid results towards effective decision-making. For more information, visit BSSI’s website at: http://www.biostatsolutions.com.
About 3DS
3DS (TSX-V:DXD; OTCQB:TDSGF; FSE:3D0) is a personalized medicine company with a proprietary software platform, TeloViewTM, that is designed to predict the course of certain diseases and to tailor treatment options for the individual patient. The technology is based on the three-dimensional analysis of telomeres, the protective caps at the ends of chromosomes. 3DS’ TeloViewTM software platform measures the organization of the genome and its correspondence to; the stage of a given disease, the rate of progression of the disease, how different diseases will respond to various therapies, and a drug’s efficacy and toxicity. 3DS’ proprietary imaging software is designed to go beyond identifying whether a patient suffers from a specific disease or condition. Instead, the TeloViewTM platform is designed to inform clinicians and patients with respect to how to personalize treatment and best manage an individual’s disease based on their unique TeloView ScoreTM. As healthcare moves increasingly toward better informed, patient-centric approaches, the Company intends for the TeloViewTM platform to deliver personalized medicine that allows for better treatments, leading to better outcomes.
The TeloViewTM platform is supported by 25 clinical studies involving more than 3,000 patients and 20 different cancers, plus Alzheimer’s disease. 3DS benefits from twenty years of research, $25M of non-dilutive investment into its platform and more than 130 supporting publications, and holds a portfolio of patents related to three-dimensional telomere analysis for proliferative diseases, including (but not limited to) hematological disorders such as Hodgkin's lymphoma, multiple myeloma, and chronic myeloid leukemia. 3DS’ intellectual property portfolio also covers prostate cancer, breast cancer, lung cancer, melanoma, colorectal cancer, and Alzheimer disease.
For more information, visit the Company’s website at: http://www.3dsignatures.com.
For further information, please contact:
Jason Flowerday
CEO & Director
416-673-8487
investors@3dsignatures.com
Viveve Medical Inc. is a great company and so is 3D Signatures Inc.
OTC:TDSGF
http://bit.ly/2BtO18h
Dear Friends of 3D Signatures:
We're pleased to share a short and informative update on the Company's plans to advance its novel TeloView(TM) platform as featured on the Worldwide Business with Kathy Ireland©. 3D Signatures' CEO, Jason Flowerday, along with members of the management team and Board discuss the Company's progress to date and their plans to leverage its proprietary 3D telomere software to personalize medicine across a number of different cancers.
3D Signatures featured on Worldwide Business with kathy ireland®
Tight Zinc Supply
Mining Capital's Alastair Ford says zinc, the metal used to make steel, is soaring in price due to the global economy marching forward and a strong demand for all sorts of metals.
This bodes well for Blue Moon going forward into 2018 and beyond. With a PEA looming on the near horizon, investors in MOON, are going to have galvanized smiles in the months ahead.
http://bit.ly/2nOrFGW
BLUE MOON ANNOUNCES $520,000 FINANCING
February 7, 2018 – Blue Moon Zinc Corp. (TSXV: MOON; US OTC: BMOOF) (the “Company”) announces it has arranged a non-brokered private placement of $520,000 at a price of $0.10 per unit (the “Unit) with each Unit consisting of one common share and one common share purchase warrant (a “Warrant”).
Each Warrant shall entitle the holder thereof to acquire one common share at a price of $0.15 per share for a period of 24 months. In the event the closing price of the Company’s common shares exceeds $0.22 per share for ten consecutive trading days, the Company may accelerate the date of the Warrants by giving notice to the holders thereof and in such case the Warrants will expire on the 30th day after the day on which such notice is given by the Company. Officers and directors will be participating in the financing. Proceeds of the financing will include the cost of finalizing the anticipated drill permit, general working capital and marketing of the Company.
About Blue Moon
The Company owns 100% of the Blue Moon polymetallic zinc deposit with significant credits of copper, silver and gold. The deposit is open at depth and along strike and historical metallurgical testing indicates excellent recovery and a clean zinc concentrate. A NI 43-101 report detailing the resource and summarizing metallurgical recoveries is available on the company’s website (www.bluemoonmining.com) and filed on SEDAR on November 13, 2017. The Company plans to advance the Blue Moon project through to feasibility, permitting and ultimately production.
For more information please contact:
Patrick McGrath, CEO
1-832-499-6009
pmcgrath@bluemoonmining.com
For additional information related to communications, media relations and investor relations please contact:
Terry Bramhall
1-604-833-6999
tbramhall@bluemoonmining.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.Resource estimates included in this news release are forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions set forth in the relevant technical report and otherwise, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices for zinc, the results of future exploration, uncertainties related to the ability to obtain necessary permits, licenses and titles, changes in government policies regarding mining, continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Readers are cautioned not to place undue reliance on this forward-looking information, which is given as of the date it is expressed in this press release, and the Company undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws.
The securities referenced in this news release have not and will not be registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
Zinc price will vault $4,000 within months – report
In a research report consultants, Wood Mackenzie said the combination of scheduled mine closures, top producer Glencore's strategic cuts and the impact of environmental inspections in China has depleted global stocks of concentrate.
According to the report global zinc stockpiles fell by a third in 2017 to 1.8 million tons, equivalent to 47 days of global usage. Exchange stocks halved from 500kt to 250kt (equivalent to just 6 days of global consumption) over the same period.
By the end of the second quarter, there will be less than 40 days’ of stock available for consumers; "a critically low level" according to the authors which should propel prices to $4,000 a tonne in the third quarter of this year.
Zinc price will vault $4,000 within months – report However, says Woodmac, zinc has the potential to rally even further:
"As the rapid escalation of the price thus far in 2018 has demonstrated, there is a strong possibility that investor
enthusiasm will pre-empt the tightness in the refined market and the cyclical peak in the price could be higher and sooner than
our base case assumption of a Q1 2019 average of $4,100/t."
Please see the attached link featuring a 3D Signatures video interview with CEO Jason Flowerday
as well as other members of the 3D team explaining the benefits of the 3D Signatures diagnostic platform.
http://bit.ly/2DOkzeD
https://vimeopro.com/kathyireland/3d-signatures
BLUE MOON QUOTED ON PINK SHEETS AND DTC ELIGIBLE; POSITIVE IMPACT FROM US CORPORATE TAX RATE REDUCTION
January 23, 2018 – Blue Moon Zinc Corp. (TSXV: MOON; US OTC: BMOOF) (the “Company”) is pleased to report that the common shares of the Company are now quoted for trading in the United States on the OTC Pink Sheets under the trading symbol BMOOF. In addition, the Company’s common shares are eligible for delivery and depository services of The Depository Trust Company (the “DTC”) to facilitate electronic settlement of transfers of its common shares in the United States. Securities that are eligible to be electronically cleared and settled through the DTC are considered “DTC eligible.” This electronic method of clearing securities speeds up the receipt of stock and cash, and thus accelerates the settlement process for investors and greatly reduces transactional costs for participating stock brokerages. Investors can find the current Canadian financial disclosure of the Company on www.sedar.com.
Effective January 1, 2018, corporate tax rates in the United States were reduced from 35% to 21%, among other changes favoring US businesses. The Company’s Blue Moon zinc deposit is domiciled in the US and the corporate tax reduction is expected to be beneficial to the project and the Company’s Preliminary Economic Assessment (“PEA”) expected to be released in late Q1 2018.
Patrick McGrath, Chief Executive officer, stated, "The US quotation with DTC eligibility should enhance and simplify trading of our shares in the US. The Company’s Blue Moon Zinc deposit is based in the US and we believe being quoted and tradable in the US is complimentary. We also welcome the recent US corporate tax reduction to 21% which we believe will improve the economics in the upcoming PEA"
About Blue Moon
The 100% owned Blue Moon polymetallic deposit has a Mineral Resource estimate of 3.7 million indicated tons with a grade of 8.3% zinc equivalence including approximately 377 million pounds of zinc and 4.1 million inferred tons with a grade of 7.8% zinc equivalence including approximately 395 million pounds of zinc with significant credits of copper, silver and gold. The resource is open at depth and along strike and historical metallurgical testing indicates excellent recovery and a clean zinc concentrate. A NI 43-101 report detailing the resource and summarizing metallurgical recoveries is available on the company’s website (www.bluemoonmining.com) and filed on SEDAR on November 13, 2017. The Company plans to advance the Blue Moon project through to feasibility, permitting and ultimately production.
Qualified Persons
Jack McClintock, P. Eng, a Director of the Company, is a qualified person as defined by NI 43-101, has reviewed the scientific and technical information that forms the basis for this press release.
www.bluemoonmining.com
For more information please contact:
Patrick McGrath, CEO
1-832-499-6009
pmcgrath@bluemoonmining.com
For additional information related to communications, media relations and investor relations please contact:
Terry Bramhall
1-604-833-6999
tbramhall@bluemoonmining.com
Stock Syndicate "Blue Moon Zinc" feature
Zinc in California $$
MOON.V
January 19, 2018 by EndzoneGreen Leave a Comment
Blue Moon ($MOON.V) has agreed to buy b
image: http://stocksyndicate.com/wp-content/uploads/2018/01/MOON.V-300x196.png
MOON.Vack a 10-per-cent net profit interest (NPI) on the company’s 100-per-cent-owned Blue Moon zinc project. The NPI was originally issued in 1987 pursuant to a transaction between Westmin Resources (now Boliden) and Colony Pacific Exploration (now Imperial Metals). The current NPI holder, Northern Empire Resources, has agreed to accept $20,000 cash and the issuance of three million common shares of the company in return for the buyback. Good sign for shareholders that they are taking such a large chunk in shares.
Patrick McGrath, CEO and Director, Blue Moon Zinc
CEO Patrick McGrath stated: “The buyback of the NPI solidifies our ownership and economic interest in the Blue Moon project. We believe the buyback will be accretive to the project and deliver significant value to our shareholders over the long term including our preliminary economic assessment (PEA) expected later in Q1 2018.”
The Blue Moon polymetallic deposit has a mineral resource estimate of 3.7 million indicated tons with a grade of 8.3 per cent zinc equivalence including approximately 377 million pounds of zinc and 4.1 million inferred tons with a grade of 7.8 per cent zinc equivalence including approximately 395 million pounds of zinc with significant credits of copper, silver and gold. The resource is open at depth and along strike and historical metallurgical testing indicates excellent recovery and a clean zinc concentrate. Blue Moon plans to advance the zinc project through to feasibility, permitting and ultimately production. Giddy up. http://bit.ly/2DsY92y
www.bluemoonmining.com
TSX-V-MOON OTC-BMOOF
Investor Relations
1-604-833-6999
BLUE MOON ANNOUNCES AGREEMENT TO BUYBACK 10% NPI
January 18, 2018 – Blue Moon Zinc Corp. (TSXV: MOON; US OTC: BMOOF) (the “Company”) is pleased to announce that it has agreed to buyback a 10% Net Profit Interest (“NPI”) on the Company’s 100% owned Blue Moon zinc project. The NPI was originally issued in 1987 pursuant to a transaction between Westmin Resources Limited (now Boliden) and Colony Pacific Exploration Ltd. (now Imperial Metals). The current NPI holder, Northern Empire Resources Corp., has agreed to accept $20,000 cash and the issuance of 3 million common shares of the Company in return for the buyback.
Patrick McGrath, Chief Executive Officer, stated “The buyback of the NPI solidifies our ownership and economic interest in the Blue Moon project. We believe the buyback will be accretive to the project and deliver significant value to our shareholders over the long term including our Preliminary Economic Assessment (“PEA”) expected later in Q1 2018.”
The Company also granted 1,000,000 stock options to consultants, each option being exercisable for a five-year term at a price of $0.08 per common share. The options are governed by the terms and conditions of the Company’s stock option plan.
About Blue Moon
The 100% owned Blue Moon polymetallic deposit has a Mineral Resource estimate of 3.7 million indicated tons with a grade of 8.3% zinc equivalence including approximately 377 million pounds of zinc and 4.1 million inferred tons with a grade of 7.8% zinc equivalence including approximately 395 million pounds of zinc with significant credits of copper, silver and gold. The resource is open at depth and along strike and historical metallurgical testing indicates excellent recovery and a clean zinc concentrate. A NI 43-101 report detailing the resource and summarizing metallurgical recoveries is available on the company’s website (www.bluemoonmining.com) and filed on SEDAR on November 13, 2017. The Company plans to advance the Blue Moon project through to feasibility, permitting and ultimately production.
Qualified Persons
Jack McClintock, P. Eng, a Director of the Company, is a qualified person as defined by NI 43-101, has reviewed the scientific and technical information that forms the basis for this press release.
For more information please contact:
Patrick McGrath, CEO
1-832-499-6009
pmcgrath@bluemoonmining.com
For additional information related to communications, media relations and investor relations please contact:
Terry Bramhall
1-604-833-6999
tbramhall@bluemoonmining.com
Streetwise Reports Features 3D Signatures
Test for Personalized Approach to Hodgkin's Lymphoma
Treatment Entering Final Stages Before Commercialization
Source: Streetwise Reports (1/16/18)
One analyst believes 2018 could mark a 'dramatic turnaround' for this biotech company,
which is at the forefront of using three-dimensional telomere analysis to personalize
medical treatment.
3D Signatures Inc. (DXD:TSX.V; TDSGF:OTCQB; 3D0:FSE) has developed a propriety software platform, TeloView, that conducts 3D analysis of chromosomal signatures. "Depending on the desired application, this platform technology can measure the stage of disease, rate of progression of disease, drug efficacy, and drug toxicity," the company has noted. The analytics can tell "doctors how to personalize treatment and best manage the disease for each individual patient."
The firm completed a Stage 3 clinical trial component for its Hodgkin's lymphoma test, Telo-HLTM, in October; the test is powered by their proprietary TeloViewTM software platform. The aim of the Telo- HLTM test is to divide patients at the point of diagnosis into those who will respond to standard chemotherapy and those who will not, and should be considered for a more targeted, and expensive, second-line therapy.
Currently, patients for whom the standard chemotherapy treatment fails then have to go on to a number of additional interventions and more aggressive alternative treatments. Patients with a relapsing form of the disease often are weakened by the initial chemo treatments so they do not respond as well to the subsequent treatment.
While about 80% of Hodgkin's patients respond to the standard chemotherapy regimen, 3D Signatures CEO Jason Flowerday told Streetwise Reports that the goal of the test is to identify the 20% of patients who will relapse and require additional therapies, to save them from treatments that are unlikely to succeed. In addition, the company believes that its Telo-HLTM test could "provide significant cost savings to payors and insurers that
are currently burdened with expensive treatments and procedures that may not be necessary if patients could be considered for more targeted and effective therapies at the outset of treatment."
3D Signatures is now having the Telo-HLTM data validated by a third-party statistical provider, as well as preparing for validation of the scoring model. If both validations are successful, the company plans to make the
test commercially available in the coming months. In addition to the Hodgkin's lymphoma test, 3D Signatures is developing diagnostic and prognostic products
for prostate cancer, multiple myeloma and lung cancer, all at various stages of development, and finally for Alzheimer's disease, a diagnostic test that has successfully completed two blinded research studies.
On Jan. 5, Daniel Carlson of Tailwinds Research Group noted that for 3D Signatures, "2017 was a year to forget. The stock went down dramatically on the back of a very poor financing effort. However, like the Phoenix, sometimes big disasters can turn into outstanding revivals. 3DS is poised to enter into several
partnerships for its interesting technology. Meanwhile, the stock's valuation discounts all success. I expect shares to advance in lockstep with the company's development of their telomere technology and for 2018 to mark a dramatic turnaround for the Company."
3D Signatures has approximately 63 million shares outstanding with about 27% controlled by insiders. The company's market cap is approximately CA$18 million.
Read more at http://www.stockhouse.com/companies/bullboard/v.dxd?postid=27376865#6fxIb8l3cQ0ZhOcq.99
Zinc Prices Hit Fresh 10 Year High on Weaker US Dollar
Base metals rallied on Monday, with zinc prices climbing to a fresh decade high on the back of a weaker US dollar and lower inventories.
Zinc prices climbed to a fresh decade high on Monday (January 15), supported by a weaker US dollar and declining inventories.
LME zinc closed up 1.2 percent, at $3,423 a tonne, having touched a peak of $3,440 earlier in the day — its highest level since August 2007.
Overall it’s been a strong start of the year for the base metal, with prices increasing 1.4 percent year-to-date and more than 20 percent year-on-year.
Some analysts believe zinc prices might jump even further in 2018, as solid Chinese data, a weaker dollar and falling inventories continue to lend support.
“The bullish view has become the consensus in the market, and it’s very hard to see a deep correction in prices from here,” Richard Fu, head of Asia Pacific sales at Amalgamated Metal Trading, told Bloomberg.
On Monday, a falling US dollar supported a surge in all base metals, as a softer greenback makes commodities priced in dollars cheaper for investors using other currencies.
“It is a dollar story … which is behind this move,” said ING analyst Warren Patterson. “If you look at the speculative position in the metals, there is potential for further upside, if we continue to get positive economic data and strong manufacturing data.”
For Patterson, the zinc market is going to be “fairly tight” at least for the first half of the year, as investor fears over shrinking supply and a lack of new mine production continue to increase.
Supply-side concerns have also been fuled by declining warehouse inventories. Last week, LME zinc stocks fell for a 13th week, reaching their lowest level since October 2008. On Monday, on-warrant zinc inventories fell by another 10,000 tonnes to reach 116,675 tonnes.
“Prices will stay elevated because we have a market deficit that requires inventory drawdown,” Societe Generale (EPA:GLE) analyst Robin Bhar said last week.
Firms recently polled by FocusEconomics estimate that zinc prices will average $3,009 in 2018. The most bullish forecast for the year comes from TD Economics, which is calling for a price of $3,362; Danske Bank (CPH:DANSKE) is the most bearish with a forecast of $2,650.
Don’t forget to follow us @INN_Resource for real-time news updates
Zinc Powers Higher as Inventories Hit 10-year Low
Charlotte McLeod • January 11, 2018
Zinc prices continued to thrive this week, spurred higher by declining inventories and a lack of new mine supply.
The base metal reached $3,400 per tonne, its highest point since August 2007, on Tuesday (January 9) after nearing $3,350 earlier in the month.
Prices crossed the $3,000 mark last summer, and ultimately surged nearly 30 percent over the course of 2017. While many experts are calling for a more balanced market this year, it is expected to take some time for that balance to emerge.
“Prices will stay elevated because we have a market deficit that requires inventory drawdown,” Societe Generale (EPA:GLE) analyst Robin Bhar told Reuters on Tuesday.
“New supply and demand destruction due to zinc substitution will eventually rebalance the market, but that could take months, if not years,” he added, noting that new supply from small mines in Canada and Australia will not be enough to even out the current supply/demand imbalance.
According to a Scotiabank report released this week, LME zinc inventories currently stand at 180,175 tonnes, which is about a 10-year low. Meanwhile, global zinc stocks are at 419,000 tonnes, up 3.5 percent since the start of 2018, but down 44.7 percent year-to-date.
“Prices will stay elevated because we have a market deficit that requires inventory drawdown,” Societe Generale (EPA:GLE) analyst Robin Bhar told Reuters on Tuesday.
“New supply and demand destruction due to zinc substitution will eventually rebalance the market, but that could take months, if not years,” he added, noting that new supply from small mines in Canada and Australia will not be enough to even out the current supply/demand imbalance.
According to a Scotiabank report released this week, LME zinc inventories currently stand at 180,175 tonnes, which is about a 10-year low. Meanwhile, global zinc stocks are at 419,000 tonnes, up 3.5 percent since the start of 2018, but down 44.7 percent year-to-date.
image: https://investingnews.com/wp-content/uploads/global-zinc-inventories.png
global-zinc-inventories
Global zinc inventories from March 2011 to January 2018. Chart via Scotiabank.
It’s worth noting that if zinc prices continue to rise, demand for the metal could eventually fall due to substitution. In an article published this week, American Metal Market notes that if substitution occurs it will most likely happen in the alloys sector.
“If zinc prices surge to above $3,500 per tonne, we will see a drop in consumption,” the news outlet quotes an unnamed executive at a major zinc producer as saying. “If there’s an opportunity created by the zinc price being too expensive, people will just go for other materials. And they are not coming back.”
For now, however, zinc’s future remains bright. Firms polled recently by FocusEconomics estimate that the average zinc price for 2018 will be $3,009. The most bullish forecast for the year comes from TD Economics, which is calling for a price of $3,362.
http://bit.ly/2ARLqBg
Terry Bramhall
Investor Relations
Blue Moon Zinc Mining
604-833-6999
www.bluemoonmining.com
Going To The Moon! 10-15 Cent Target 1st Quarter
We initially brought Blue Moon Zinc (MOON, TSX-V) to the attention of subscribers last September as an astute buy when it was trading between about 5 and 7 cents. It quickly ran up to 11 cents at the beginning of October before settling back down to strong support.
What we like a lot about Blue Moon is its Zinc project in the foothills of northern California – a deposit with a significant NI-43–101 resource that’s wide open for expansion at depth and along strike (currently 3.7 million tons in the Indicated category grading 8.3% Zinc equivalent and 4.1 million tons of Inferred @ 7.8% ZnEq, both at a ZnEq cut-off grade of 4%).
Admittedly, California is not our favorite jurisdiction for mining – far too many environmental wackos down there. However, location is everything and the Blue Moon deposit has the advantage of being within a county that’s a Republican stronghold and very pro-business and pro-mining. Drill permits won’t be a problem and by all reports, county officials are eager to see this project go into production. This would be an underground operation with a limited environmental footprint at surface.
Mine Development Associates Inc. (MDA) has a solid reputation and is carrying out the PEA. MDA co-authored a 2015 feasibility study for the Soledad Mountain mine in Southern California that went into commercial production in December 2016. With sweeping tax reform in the United States, recently passed by Congress and signed by President Trump, the economics for Blue Moon should be more robust than ever, and of course Zinc prices just hit a new decade high.
MOON has about 90 million shares outstanding (no warrants) for a current market cap of $8 million based on today’s closing price of 9 cents. The move past 6 cents certainly triggered technical buying and strong volume came into the stock today.
It’s very hard in the current market to find a quality resource opportunity under 10 cents. We expect accumulation to continue with plenty of trading to occur in the 10 to 15-cent range this quarter, as you can see in the chart, in advance of the PEA and drilling to expand the resource.
http://www.bullmarketrun.com/wp-content/uploads/2018/01/MOON-Jan-10.jpg
3D Signatures bullish profile in Tailwinds Research for 2018
By Daniel Carlson - January 5, 2018
3-D Signatures (DXD.V): for 3DS, 2017 was a year to forget. The stock went down dramatically on the back of a very poor financing effort. However, like the Phoenix, sometimes big disasters can turn into outstanding revivals. 3DS is poised to enter into several partnerships for its interesting technology. Meanwhile, the stock’s valuation discounts all success. I expect shares to advance in lockstep with the company’s development of their telomere technology and for 2018 to mark a dramatic turnaround for the Company.
http://bit.ly/2D4nUUc
Reduction of US Corporate Tax is beneficial for Blue Moon Zinc
The new reduction of American corporate tax should have a substantial impact on Blue Moon's ongoing PEA re: profitability with it's proposed development to production of their Zinc, Copper Silver, Lead ore-body.
www.bluemoonmining.com
3D Signatures Inc. Announces the Closing of its Non-Brokered Private Placement
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO, Dec. 05, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS") is pleased to announce that its previously disclosed non-brokered private placement (the “Private Placement”) has been fully subscribed for and has closed for aggregate gross proceeds to 3DS of $1,622,673.
The Private Placement involved the sale of 8,113,365 units (the “Units”) at a price of $0.20 per Unit. Each Unit consists of one common share of the Company and one common share purchase warrant exercisable at $0.35 until December 5, 2022. All securities issued pursuant to the Private Placement are subject to a four month hold period in accordance with applicable Canadian securities laws.
In connection with the Private Placement, the Company paid certain finders a cash commission totalling $91,704, equal to 6% of the gross proceeds raised under the Private Placement by these finders, and issued such finders a total of 458,520 non-transferrable warrants (each, a “Finder’s Warrant”), equal to 6% of the number of Units issued by the Company to investors introduced to the Company by these finders. Each Finder’s Warrant is exercisable to purchase one common share until December 5, 2019 at an exercise price of $0.35.
The Company intends to use the net proceeds from the Private Placement to fund clinical trials, and for working capital and general corporate purposes. The Company expects that approximately $750,000 of the Private Placement will be used to fund clinical expenses, including the Company’s test for Hodgkin’s lymphoma, Telo-HL™, which requires validation of the scoring model as well as analytical validation prior to expected commercial launch as a laboratory developed test (“LDT”) in the first quarter of 2018. The balance of the Private Placement is expected to be used to fund general working capital expenses.
"We greatly appreciate the confidence shown in 3DS by the investors who participated in this financing,” commented Jason Flowerday, CEO of 3DS. “This financing has provided us with resources to continue implementing our strategic plan, which includes the anticipated commercial launch of our Hodgkin’s lymphoma test as an LDT in Q1 2018.”
Certain insiders of the Company participated in the Private Placement by purchasing an aggregate of 230,000 Units. Accordingly, the Private Placement constitutes, to that extent, a "related party transaction" under applicable Canadian securities laws. The Company is relying on the exemptions from the formal valuation and minority approval requirements found in sections 5.5(a) and section 5.7(1)(a) of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions as the fair market value of the transaction, insofar as it involves interested parties, is not more than the 25% of the Company’s market capitalization. The Company did not file a material change report more than 21 days before the expected closing of the Private Placement as the details of the Private Placement and the participation therein by related parties of the Company were not settled until shortly prior to closing and the Company wished to close on an expedited basis for sound business reasons.
This press release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “1933 Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the 1933 Act and applicable state securities laws or an exemption from such registration is available.
About 3DS
3DS (TSX-V:DXD; OTCQB:TDSGF; FSE:3D0) is a personalized medicine company with a proprietary software platform based on the three-dimensional analysis of chromosomal signatures. The technology is well developed and supported by 22 clinical studies on over 2,000 patients on 13 different cancers and Alzheimer’s disease. Depending on the desired application, this platform technology can measure the stage of disease, rate of progression of disease, drug efficacy, and drug toxicity. The technology is designed to predict the course of disease and to personalize treatment for the individual patient. For more information, visit the Company’s website at: http://www.3dsignatures.com.
For further information, please contact:
Jason Flowerday
CEO & Director
604-428-8842
investors@3dsignatures.com
3D Signatures Inc. Announces Upsizing of $1,500,000 Private Placement, the Appointment of a New Director and Reports on AGM Results
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO, Dec. 01, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS") is pleased to announce an upsize of its previously announced non-brokered private placement and the results of its Annual General Meeting of Shareholders held on November 28, 2017 (“AGM”).
Private Placement
3DS announces that the Company is increasing its previously announced non-brokered private placement, from total gross proceeds of $1,500,000 to total gross proceeds of up to $1,622,673 (the “Private Placement”). The Private Placement will now consist of 8,113,365 units (the “Units”) at a price of $0.20 per Unit. Each Unit will consist of one common share of the Company and one common share purchase warrant exercisable at $0.35 for 5 years from the date of the closing of the Private Placement.
As previously announced, the Company has agreed (i) to pay a cash finder’s fee of 6% of the aggregate proceeds raised from subscriptions arranged by certain finders and (ii) to issue broker warrants equal to 6% of the aggregate Units subscribed for pursuant to the subscriptions arranged by such finders. Each broker warrant shall be exercisable for one common share at a price of $0.35 for a period of 2 years following the closing date of the Private Placement.
The closing of the Private Placement is expected to occur on or about December 4, 2017, and is subject to the receipt of all necessary regulatory approvals, including the approval of the TSX Venture Exchange. All securities issued pursuant to the Private Placement will be subject to a four month hold period in accordance with applicable Canadian securities laws. There is no material fact or material change regarding 3DS that has not been generally disclosed. In the event that 3DS receives subscriptions above the revised stated maximum amount of the Private Placement, 3DS will adjust the subscriptions received on a pro-rata basis or will increase the size of the Private Placement accordingly.
The Company intends to use the net proceeds from the Private Placement to fund clinical trials, and for working capital and general corporate purposes. The Company expects that approximately $750,000 of the Private Placement will be used to fund clinical expenses, including the Company’s test for Hodgkin’s lymphoma, Telo-HLTM, which requires validation of the scoring model as well as analytical validation prior to expected commercial launch as a laboratory developed test (“LDT”) in the first quarter of 2018. The balance of the Private Placement is expected to be used to fund general working capital expenses.
AGM
At the AGM, shareholders approved the appointment of all directors proposed for election, which comprised the existing slate of directors and Ian Fodie. Shareholders also approved the reappointment of MNP LLP as the Company’s auditor.
Ian Fodie is the principal of IF Only Strategies Ltd. Prior thereto, he served as either Chief Financial Officer to, or in other executive management positions of, such corporations as NRI Global, First Bauxite Corporation, Lithium Americas Corp., Oriental Minerals Inc., Longview Capital Partners Inc., Mainframe Entertainment Inc., Historical Xperiences Inc., Sextant Entertainment Group Inc., International Keystone Entertainment Inc. and Vividata, many of which were traded on either the TSX or TSX Venture Exchange. Mr. Fodie has sat on the board of directors of many companies including Peace Arch Entertainment Group Inc., Oriental Minerals Inc., Woulfe Mining Corp. and Endeavour for the Benefits of the Art, Sciences and Health. Mr. Fodie’s appointment is subject to approval from the TSX Venture Exchange.
In addition, subject to approval from the TSX Venture Exchange, shareholders approved at the AGM a change of 3DS’ registered and records office to Blake, Cassels & Graydon LLP, 199 Bay Street, Suite 4000, Commerce Court West, Toronto, Ontario, M5L 1A9.
This press release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “1933 Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the 1933 Act and applicable state securities laws or an exemption from such registration is available.
About 3DS
3DS (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) is a personalized medicine company with a proprietary software platform based on the three-dimensional analysis of chromosomal signatures. The technology is well developed and supported by 22 clinical studies on over 2,000 patients on 13 different cancers and Alzheimer’s disease. Depending on the desired application, this platform technology can measure the stage of disease, rate of progression of disease, drug efficacy, and drug toxicity. The technology is designed to predict the course of disease and to personalize treatment for the individual patient. For more information, visit the Company’s website at: http://www.3dsignatures.com.
For further information, please contact:
Jason Flowerday
CEO & Director
604-428-8842
investors@3dsignatures.com
3D Signatures Inc. Announces Non-Brokered Private Placement to Raise $1,500,000 and Updates Previously Announced Brokered Private Placement
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO, Nov. 27, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS") is pleased to announce its intention to raise $1.5 million CAD by way of a non-brokered private placement of 7,500,000 units (the “Units”) at a price of $0.20 per Unit (the “Private Placement”). Each Unit will consist of one common share of the Company and one common share purchase warrant exercisable at $0.35 for 5 years from the date of the closing of the Private Placement.
The Company has agreed (i) to pay a cash finder’s fee of 6% of the aggregate proceeds raised from subscriptions arranged by certain finders and (ii) to issue broker warrants equal to 6% of the aggregate Units subscribed for pursuant to the subscriptions arranged by such finders. Each broker warrant shall be exercisable for one common share at a price of $0.35 for a period of 24 months following the closing date of the Private Placement.
The closing of the Private Placement is expected to occur on or about November 30, 2017, and is subject to the receipt of all necessary regulatory approvals, including the approval of the TSX Venture Exchange. All securities issued pursuant to the Private Placement will be subject to a four month hold period in accordance with applicable Canadian securities laws. There is no material fact or material change regarding 3DS that has not been generally disclosed.
The Company intends to use the net proceeds from the Private Placement to fund clinical trials, and for working capital and general corporate purposes. The Company expects that approximately $750,000 of the Private Placement will be used to fund clinical expenses, including the Company’s test for Hodgkin’s lymphoma, Telo-HLTM, which requires validation of the scoring model as well as analytical validation prior to expected commercial launch as a laboratory developed test (“LDT”) in the first quarter of 2018. The balance of the Private Placement is expected to be used to fund general working capital expenses.
Separately, 3DS announces the termination of a previous agreement, announced on October 25, 2017, pursuant to which Haywood Securities Inc. (“Haywood”) agreed, on behalf of a syndicate of agents including Industrial Alliance Securities Inc., to sell, by way of a brokered private placement on a best efforts basis, units of the Company at a price of $0.25 per unit for aggregate gross proceeds of up to $2,500,000. In accordance with the terms of the engagement letter, the Company agreed to pay all reasonable fees and expenses, including legal fees and disbursements, incurred by the agent or on their behalf.
This press release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “1933 Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the 1933 Act and applicable state securities laws or an exemption from such registration is available.
About 3DS
3DS (TSX-V: DXD; OTCQB: TDSGF; FSE: 3D0) is a personalized medicine company with a proprietary software platform based on the three-dimensional analysis of chromosomal signatures. The technology is well developed and supported by 22 clinical studies on over 2,000 patients on 13 different cancers and Alzheimer’s disease. Depending on the desired application, this platform technology can measure the stage of disease, rate of progression of disease, drug efficacy, and drug toxicity. The technology is designed to predict the course of disease and to personalize treatment for the individual patient. For more information, visit the Company’s website at: http://www.3dsignatures.com.
For further information, please contact:
Jason Flowerday
CEO & Director
604-428-8842
investors@3dsignatures.com
Cautionary Note Regarding Forward-Looking Statements
This news release contains forward looking statements which constitute “forward looking information” within the meaning of applicable Canadian securities legislation (“Forward Looking Statements”). All statements included herein, other than statements of historical fact, are Forward Looking Statements and are subject to a variety of known and unknown risks and uncertainties which could cause actual events or results to differ materially from those reflected in the Forward-Looking Statements. The Forward Looking Statements in this news release include, without limitation, statements about the use of proceeds of the Private Placement, 3DS’ ability to complete the Private Placement, including obtaining the necessary approvals in connection therewith, 3DS’ expected clinical trials and research and development initiatives, the development and commercialization of the Telo-HLTM test as an LDT by the first quarter of 2018, the expected closing date of the Private Placement, the payment of finder’s fees in respect of the Private Placement and the possibility that the Company may increase the size of the Private Placement or allot subscriptions on a pro-rata basis in the event of the Private Placement being oversubscribed. Often, but not always, these Forward-Looking Statements can be identified by the use of words such as "estimates", "potential", "open", "future", "assumes", "projects", “anticipates”, “believes”, “may”, “continues”, “expects”, "plans", "will", "to be", or statements that events "could" or "should" occur or be achieved, and similar expressions, including negative variations.
Such Forward Looking Statements reflect the Company’s current views with respect to future events, are subject to risks and uncertainties and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by 3DS as of the date of such statements, are inherently subject to significant medical, scientific, business, economic, competitive, political and social uncertainties and contingencies. Many risk factors could cause the Company’s actual results, performance, achievements, prospects or opportunities to be materially different from any future results, performance or achievements that may be expressed or implied by such Forward Looking Statements, including the risk that the Private Placement may not close; the risk that 3DS’ management will have discretion in the actual application of the net proceeds and may elect to allocate proceeds differently from what is described herein; the risk that the Telo-HLTM test may not be commercially launched as an LDT by the first quarter of 2018, or at all; the risk that 3DS’ management may elect to allot subscriptions on a pro-rata basis in the event that the Private Placement is oversubscribed; risks related to the volatility of the price of 3DS’ common shares; risks related to the possibility that 3DS’ shareholders may experience dilution; risks related to 3DS’ requirements for additional financing and future access to capital, including the risk that the proceeds raised under the Private Placement may be insufficient to finance 3DS’ business objectives; the risk that a positive return on an investment in 3DS’ common shares is not guaranteed; uncertainties related to 3DS’ clinical trials and test development; risks related to 3DS’ intention to retain earnings and not pay cash dividends on its common shares in the foreseeable future; risks related to 3DS’ early stage of development; the risk that 3DS’ tests will not be successfully deployed; risks related to 3DS’ dependence on third parties, including collaborative partners, licensors and others; risks related to 3DS’ clinical trial recruitment; that there is currently no market for 3DS’ products and that such market may be slow to develop if at all; risks related to 3DS’ reliance on key personnel; risks related to the competitive nature of the biotechnology industry; risks related to 3DS’ limited operating history, lack of revenue, history of losses and inability to assure that it will earn profits in the future or that profitability will be sustained; risks related to government regulation; risks related to rapid technological change; risks related to the fact that 3DS’ software may now or in the future contain undetected errors, bugs or vulnerabilities; the risk that 3DS or its directors and officers may be subject to a variety of civil or other legal proceedings, with or without merit, including product liability claims; risks related to the protection of 3DS’ intellectual property rights; risks related to 3DS’ limited sales, marketing and distribution experience; risks related to the possibility that 3DS’ directors and officers may be placed in a conflict of interest as a result of their employment or affiliation with third parties, risks related to 3DS’ use and storage of personal information and compliance with applicable privacy laws, as well as those risks discussed under the heading "Risk Factors" in the Company's management’s discussion and analysis dated October 23, 2017 and filed on SEDAR. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in the Forward-Looking Statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended.
In making the Forward Looking Statements, the Company has made various material assumptions including, but not limited to, the timely receipt of regulatory and third party approvals related to the Private Placement; the completion of the Private Placement; obtaining positive results from 3DS’ current and planned clinical trials and research and development initiatives; that the Telo-HLTM test will be commercially launched as an LDT by the first quarter of 2018; obtaining regulatory approvals with respect to 3DS’ clinical trials which are now ongoing or may in the future be commenced; 3DS’ ability to successfully develop its tests; assumptions regarding general business and economic conditions; that 3DS’ current positive relationship with third parties will be maintained; the availability of future financing on reasonable terms; 3DS’ ability to attract and retain skilled staff; assumptions regarding market competition and the products and technology offered by 3DS’ competitors; and 3DS’ ability to protect patents and proprietary rights.
3DS believes that the assumptions and expectations reflected in the Forward-Looking Statements in this press release are reasonable, but no assurance can be given that these expectations will prove to be correct. Forward Looking Statements should not be unduly relied upon. This information speaks only as of the date of this press release, and 3DS will not necessarily update this information, unless required to do so by securities laws.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Zinc prices rise to 10-year high after more than 500 jobs cut in northern Australia.
http://ab.co/2i9aX1j
Mining company Glencore's bold strategy to take about a third of its zinc off the market in 2015 has largely been credited for the mineral hitting a 10-year high.
Glencore's Lady Loretta and Mount Isa operations, as well as McArthur River in the Northern Territory, took the brunt of the 2015 supply cuts, with more than 500 jobs lost.
However, resource analyst Gavin Wendt said zinc was probably the best performing commodity in the past five years.
"If we go back to early 2016, we've actually seen a more than doubling in the price of zinc," Mr Wendt said.
Zinc is currently trading at more than $US3,000 a tonne on the London Metal Exchange and earlier in October reached a 10-year high of $US3,308 a tonne.
"It's reflective of very sound fundamentals associated with the commodity itself and by that I mean rising demand coinciding with a situation where supply has been restricted," Mr Wendt said.
Picture of John Tully
Mount Isa real estate agent John Tully says extensive cuts in zinc supply coincided with copper cuts and plummeted the population of the town. (ABC Rural: Eric Barker)
Mount Isa population declines dramatically
With a strong reliance on mining, Mount Isa in north-west Queensland, was one of the main towns impacted by the zinc production cuts.
Mount Isa in north-west Qld
Mount Isa, in north-west Queensland, was one of the main towns to suffer from the extensive job cuts. (ABC TV News, file image)
Real estate agent John Tully said Glencore's decision to restrict its zinc supply came at a time when the town's copper mine, which is about 500 metres from his office, was also scaling back.
"It was pretty dramatic because they were putting off big numbers at the mine," Mr Tully said
Mr Tully said the quick decline in population really put the pressure on the real estate market.
"During that period there were a lot of bank recoveries, but now we are coming to the end of them hopefully," he said.
"We're based on the world economy, because what we have in the ground the rest of the world needs and until the world wants it, we just have to hold our ground."
Australia takes most of the supply cuts
While Glencore's supply cuts physically took a large amount of zinc off the market, Mr Wendt said it also had a phycological impact on the market.
"When market watchers know that there is real action being taken by Glencore, which is the biggest producer of zinc in the world, then that has a big psychological impact on the market," he said.
"There's a feeling that we might see other producers falling into line with Glencore and it puts question marks over the supply side."
Glencore's restriction of supply in 2015 coincided with MMG's Century Mine operation in the Gulf of Carpentaria, which was the world's largest open-pit zinc mine, coming to the end of its life.
"The market knew it was happening, MMG had communicated this to the market for several years, that the mine life was running out and the operation was set to close," Mr Wendt said.
"Century wasn't the only mine, there were mines all around the world that fortuitously had closed within a 12-month window of each other, which has exacerbated the supply situation."
MMG Ships a load of zinc out of Karumba
A load of zinc from Century Mine leaves the Gulf of Carpentaria. (ABC Rural: Virginia Tapp)
No plans for Glencore to increase production
Glencore's chief operating officer for Australian zinc assets Greg Ashe told the ABC in August that the market was still too volatile for the company to start increasing its production.
"As little as 18 months ago we saw zinc at a five-year low and today it's at a 10-year high," Mr Ashe said.
"We would like to see a little bit more certainty in where the price is going before we bring those metal units back into production."
Mr Ashe said with the company sitting on some high-grade zinc assets it did not want to risk another drop in price.
"The thing with Lady Loretta, the next 12 months of production that comes out of there will be the highest grade, highest margin material that happens, so we need to make sure we get it right," he said.
While Glencore waited on more certainty in the market, John Tully was confident Mount Isa would make an economic comeback.
"I've always had a lot of confidence in Mount Isa; it's one of the greatest towns in Australia and it has shown it with how we've come through this last one," he said.
"Investing News Network" Video Interview Highlights Blue Moon Zinc's
CEO Patrick McGrath at New Orleans Resource Conference.
I'll remain long on Blue Moon Zinc (OTC-BMOOF) (TSX-V-MOON)
I find the Blue Moon story a compelling ground floor story to be in on and follow to production.
For a company with with a market cap.of less than $5 million the upside is exponential when one considers "MOON" is sitting on an updated 43-101 compliant zinc orebody with significant values of copper, silver and gold.
Blue Moon expects to deliver a maiden Preliminary Economic Assessment (PEA) in Q1 2018. The ore-body currently shows a mineral resource estimate of 3.7 million tons with a grade of 8.3% zinc equivalent including approximately 377 million lbs. of zinc in the indicated category and 4.1 million tons with a grade of 7.8% zinc equivalent including approximately 395 million lbs. of zinc in the inferred category including the significant credits of copper, silver and gold. The resource is open at depth and along strike. Historical metallurgical testing indicates excellent recovery and a clean zinc concentrate.
It is my expectation drilling will commence in the new year and will easily add to reserves with the ore-body open to the South and at depth. Extension of the West, Main, and Eastern zones remain untested. The potential exists to find an additional Blue Moon ore-body in the general area as polymetallic deposits are often found in pods or clusters.
As the timeline progresses I'm sure the play will come under the eye of more major companies with the ability to generate a buy out scenario.
While some patience is needed the market should clue in. Blue Moon is not an exploration play but a development play and it is my intent to add to my position as I am able. Stay tuned.
NetworkNewsWire Exclusive Audio Interview with Blue Moon Zinc Corp. (TSX.V: MOON) (OTC: BMOOF)
http://bit.ly/2fXZJzR
NEW YORK, NY--(Marketwired - Oct 6, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions for business, today announces the online availability of its interview with Blue Moon Zinc Corp. (TSX VENTURE: MOON) (OTC: BMOOF), a mineral exploration company focused on developing its advanced-stage, wholly owned Blue Moon zinc project in central California.
The interview can be heard at http://NNW.fm/BMOOF-Oct-2017
NNW's Stuart Smith opens the interview by introducing Blue Moon CEO Patrick McGrath, who has 20 years of experience in financing and executive roles in the junior mining sector. McGrath provides valuable insight into what distinguishes the Blue Moon deposit as a promising near-term development prospect for investors.
"One of the important things for this project is that a lot of the development work was done by very well established and qualified operators," says McGrath in a review of the project's decades-long history, noting much of the advance work has been completed to show Blue Moon's zinc deposit indicated 95 percent recovery. "You can have all the zinc in the deposit, but if the recovery and metallurgy don't work, it doesn't go anywhere."
Blue Moon's primary asset is zinc. The company's recently updated NI 43-101 resource estimate shows the project, to be mined by underground methods, contains approximately 377 million pounds of zinc in the indicated category and another 395 pounds of zinc in the inferred category.
"So, we believe it's the right size and scope for the project we're about to undertake," McGrath says in the interview. "Our next step is really advancing the deposit, taking it through the feasibility and permit process, and ultimately through production."
The Blue Moon team includes two key members who have worked in California and have acquired "extensive experience with either building a mine from scratch or restarting a mine and dealing with the regulatory process, as well as the successful mining operations," McGrath said.
The long-term prognosis for Blue Moon shows "a very high likelihood that this deposit just keeps going ... that it could likely double in size," said McGrath, adding the company plans to explore the likelihood that there is another Blue Moon zinc deposit at the site.
In the near term, the company will complete a preliminary economic assessment, which will highlight Blue Moon as a viable, standalone project with a short time horizon to development of the zinc asset, McGrath concluded.
About Blue Moon Zinc Corp.
Blue Moon Zinc Corp., a Canada-based exploration-stage mineral company has 100% ownership of the Blue Moon zinc project in central California. The project sits within Mariposa County, an area of active mines and exploration projects since it was part of the California gold rush era. Blue Moon's 525 acres of mineral rights are assigned to patented and unpatented claims accessible by a gravel road off a nearby highway with main utility lines nearby. The zinc deposit is open at depth and along strike with a high likelihood of expansion. Historical studies of the project site show recovery rates of 95 percent for zinc and lead, 93 percent for copper, 65 percent for silver and 70 percent for gold. Simple processing methods will produce premium concentrates with easy separation of economic minerals.
For more information, visit the company's website at www.BlueMoonMining.com
About NetworkNewsWire
A Zinc Resource Update That Is Over the Moon: Streetwise
https://www.theaureport.com/pub/na/a-zinc-resource-update-that-is-over-the-moon
Read more at http://www.stockhouse.com/companies/bullboard/v.moon
Q&A Session with CEO Patrick McGrath of Blue Moon Zinc Corp
OTC-BMOOF TSX-V-MOON
Alphastox.com
Can you please give our readers a brief overview of how and why you got involved with Blue Moon?
I became Blue Moon’s largest single shareholder in February 2017 when I accumulated a 17% stake by buying out the then largest shareholder in the open market. I bought the position because of the Blue Moon zinc project and its near-term potential. The asset is very attractive because Boliden, one of Europe’s largest zinc producer and well respected operator, did extensive work and advanced the project to a production decision. We plan to finish what they started.
What distinguishes MOON from other junior zinc companies on the TSXV?
The zinc recoveries at Blue Moon are estimated at 95% which will yield in a simple process to separate the economic minerals, including a premium zinc concentrate. Metallurgy is key for a zinc asset and is the first question you should ask when evaluating a zinc project.
The local infrastructure for Blue Moon is excellent. For example, we are within three miles of an existing paved road, one mile from a power source and an hour’s drive from a town to house and supply our future workforce. Not many projects can boast that.
Can you give us a short summary of your asset and why you feel your team is best suited to take this asset through the permitting process in California?
Blue Moon is a high-grade zinc asset that is on a pathway to permitting and production. The project has a resource estimate of 2.62 million tons with a grade of 6.01% zinc for approximately 315 million pounds of zinc in the Indicated category and 2.68 million tons with a grade of 5.98% zinc for approximately 320 million pounds of zinc in the Inferred category plus significant values of copper, silver and gold. This resources estimate was performed in 2008 utilizing a zinc price of US $0.75 per pound. The project is a past producer with 50,000 tons mined at 12% zinc during the second world war.
Our team includes two members who built successful mines in California. Local knowledge and know how is key. Lutz Klingmann recently permitting and built the Soledad mine in southern California which went into commercial production in December 2016. Larry O’Connor restarted the Mesquite mine in southern California while he was VP Operations with Western Goldfields (now New Gold).
At a $4.7M market cap company, what do you think the market is missing and where do you see the biggest upside from here?
Quite bluntly, the market doesn’t know about the Blue Moon project. The project was dormant for several decades because its situated in California. The reality was California made it tougher to permit. Now, the rest of North America has caught up to California in terms of permitting and we believe it’s an even playing field. The last mine to go into production in California was late 2016, being the Soledad Mountain mine owned by Golden Queen TSXV: GQM. Do you know when the last mine was built in the Yukon? The Minto project in 2007 owned by Capstone. Do you know who took both Soledad (California) and Minto (Yukon) through permitting and development? Lutz Klingmann, Blue Moon’s key technical advisor.
The upside is in the potential of the resource. We believe there is a very high likelihood that the resource continues at depth. The resource ends in mineralization and a few deep holes show significant zinc grades. In addition, VMS deposits are normally found in pods. There’s a high likelihood that additional pods exist along strike where soil and IP anomalies point to continued mineralization. That is the blue-sky potential.
What are a few catalysts investors should look forward to over the next six months?
The Company has several key catalysts. We expect an updated NI 43-101 report in late in September. The prior NI 43-101 resource estimate published in 2008 used $0.75 per pound zinc and $8.50 an ounce silver versus the current $1.40 per pound zinc and $18.00 an ounce silver. The updated resource estimate will utilize current commodity prices and will be a stepping stone to our second major catalyst, being our maiden Preliminary Economic Assessment (PEA). We expect our PEA study to be complete in Q1 2018 and to highlight Blue Moon’s value.
Why should investors consider MOON as a potential addition to their speculative portfolio?
Moon is attractive to investors looking for a leverage play to zinc with a near term development goal.
ZINC!
How Did Investors Miss This Boom?
Dear member,
We warned (here and here) in the first half of the year that substantially zinc prices were coming... even as far back as Q4 2012 we published a lengthy piece documenting our thesis behind higher future zinc prices. It's a metal that, when examining the global production landscape five years ago, we knew would boom out of its hibernation...
In October of 2012, when zinc traded for approximately $0.84 per pound, we stated,
"The reality that zinc is heading into a supply deficit within 12-18 months is the reason we are writing you this week. We are not going to miss out on this opportunity. Once these zinc mines across the world, which are scheduled for shut-down, close their doors forever it will be too late to begin the search for viable zinc assets of the next generation. The big players move ahead of trends. They don't join them. The preparation for a shortfall won't begin in 2014, when the supply deficit is expected to hit, but long before that. In fact, it is happening right now."
Today, zinc's price is exploding, with upward momentum appearing nowhere close to completion.
Much has been driving the frenzied buying activity for zinc - from mine closures to rising demand and falling supply in China. Relevant of late are signs the global economy is surging. Led by business optimism rising the most in 37 years in the United States, countries are reporting relatively strong growth the world over. Zinc, as detailed in our writings, is directly tied to economic output.
Global Economic Growth on the Uptrend
U.S. Q2 GDP came in at 2.6%
Canada's Q1 GDP came in at 3.7%
Japan Q2 GDP, 4%
China beat estimates reporting 6.9% Q2 GDP growth
Even the anemic and often forgotten E.U. put up GDP of 2.2% in Q2, compared with the same quarter of last year.
Naturally, this widespread economic growth is bullish for base metals and is resulting in multi-year highs for many.
On May 28th, we published a zinc-themed Weekly Volume - This Metal Could Crush Fossil Fuels. The article highlights the ongoing commercialization and future potential of rechargeable zinc batteries. While steel production is still the driving force for zinc, new sources of demand can drive investor sentiment. Zinc, copper and other traditional base metals, such as nickel, are surging to the fore of the sexy clean energy market.
Zinc price surge after Pinnacle Digest notifications
A few weeks later, on June 19th, as the price of zinc hit a multi-month low, we urged our subscribers to look closely at the base metal's fundamentals. In Investors Miss Out While Majors Acquire, we wrote that,
"Zinc, the fourth most mined metal in the world, has seen its demand steadily increase for decades. The metal is primarily used to galvanize steel, but its use in agriculture as a fertilizer to increase the productivity of soil has increased markedly in recent years. New potential applications in renewable clean energy batteries add a blue sky component to the demand side as well..."
And that,
"As more people consume greater quantities of resources every year, the search for profitable zinc mines will intensify."
Our article broke down the world's top 4 zinc mines to come online and highlighted that they are all located outside North America.
To learn about the four mines being upgraded and brought online, as well as the supply and demand fundamentals surrounding the zinc market, click here.
N.B. One caveat to rising zinc prices is Glencore. The Swiss commodity behemoth is a producer and trader of the metal. The company announced significant zinc production cuts in 2015. If Glencore reactivates even some of its offline capacity, it could send a temporary shockwave to the market.
China | Still Driving Force for Zinc
For many industrial metals, the developing world, specifically China, accounts for the bulk of demand. CNBC reported on May 19th that,
"China's refined zinc output marked its lowest in more than two years in April as the impact from the closure of major mines in places such as Australia and Ireland stifled the concentrate supplies China relies on to churn out finished metal.
The nation's 'war on pollution' has also curbed output as Beijing clamps down on mining and heavy industry in a drive to clear its skies."
Our mid-June report was a prescient warning given this week's major headline about zinc.
Shanghai skyline
China's poor air quality has tarnished its economic brand globally and created domestic health concerns which the government fears could spark an uprising. With the desire of being viewed as a leading, modernized, renewable energy focused nation, China is aggressively cracking down on antiquated mining practices. This has led to dozens of mine shutdowns and disrupted global supply for several commodities.
Image: Shanghai skyline
A UBS analyst out of Melbourne confirmed in an August 21st Reuters article that,
"Closing old and inefficient steel capacity in the 26 + 2 cities is set to cut production by 50 percent and aluminum by 30 percent, before mills and smelters elsewhere in China lift output to compensate."
Furthermore,
"(This)... is driving positive sentiment right now."
Back in May, we wrote that "...supply tightened after China reportedly shut down power to 26 zinc and lead mines in the Hunan Province amid safety and environmental concerns last year."
The Chinese government fears nothing more than an uprising by its people. As a result, it is acutely focused on economic growth and the living standards within its borders. A downturn in either and there are tens of millions, if not hundreds of millions, who could turn on them.
Today's concern for the Chinese people is air pollution; and the government is working overtime to improve it as poor air quality has resulted in thousands of lives lost in China every month. The Guardian reported, "Physicists at the University of California have found 1.6 million people in China die each year from heart, lung and stroke problems because of polluted air."
In a June article, titled China's Tangshan starts new campaign to implement steel cuts, Reuters reported,
"The major Chinese steel city of Tangshan has launched a fresh crackdown on mills that illegally restart production or violate industry overcapacity rules, according to a notice published by the China Iron and Steel Association..."
The article went on to confirm that, in Tangshan alone, the government "aims to close around 8.6 million tonnes of annual production capacity this year."
Finally,
"Hebei aims to cut major emissions by more than 15 percent by 2020 and will step up efforts to force local industries to meet their pollution targets for 2017, the official Xinhua news agency reported, citing a local government plan..."
China is curbing steel production at a time when demand is surging. According to a news.com.au article from August 7th, "Chinese rebar steel futures jumped 4 per cent to their highest in four years..."
These factors are specifically pushing zinc and nickel prices higher. Nickel traded at a multi-month high this past week.
6 month nickel price
Copper Signals Global Economy Set for Growth
Unsurprisingly, copper, also known as Dr. Copper for its price reflecting the state of the global economy, is performing exceptionally well amidst the current surge in global growth. This past week, futures for September delivery climbed above $3 per pound - the highest since November of 2014.
According to Mining.com,
"Copper's 2017 year to date gains in percentage terms now top 19% and the red metal has recovered 55% in value after falling to six-year lows below $2.00 a pound in January last year."
Positive sentiment from the U.S. economy to Japan and even the E.U. are spurring demand.
Mining truck in copper mine in Chile
Open pit copper mining operation in Chile, the world's largest producer of the base metal. China is the second biggest copper producing nation in the world.
Copper mines, plagued with strikes and bad weather, have lost nearly 10% of production in the first quarter of 2017. A major contributor was Escondida, the world's largest copper mine, which endured a 43-day strike earlier this year. Freeport McMorRan's Grasberg copper mine, the world's second largest, is currently enthralled by a worker's revolt. Reports are sketchy, but disgruntled workers have clashed with security forces. In Copper price rallies after Grasberg violence,
"Reuters reports at least seven people were injured and dozens of vehicles and buildings torched."
Copper Prices Remain in Uptrend
Copper spot price
All of these metals, in addition to gold which hit $1,300 last week, are benefiting from a weak U.S. dollar. With Trump keeping the greenback in check, and the global economy rebounding, raw materials and commodities are the assets to own at the moment. As zinc majors begin to report huge profit margins amidst the highest prices in over a decade, expect interest in the sector from generalist investors to pick up. That's when you look to take some off the table.
All the best with your investments,
PINNACLEDIGEST.COM
Maxtech amends $2-million financing
Maxtech Ventures Inc (2) (C:MVT)
Shares Issued 49,186,448
Last Close 7/26/2017 $0.21
Wednesday July 26 2017 - News Release
Mr. Peter Wilson reports
MAXTECH ANNOUNCES NEW FINANCING
Maxtech Ventures Inc. has amended the terms of its previously announced non-brokered private placement of up to $2-million.
The offering will comprise up to eight million units at a price of 25 cents per unit. Each unit will comprise one common share in the capital of the company and one share purchase warrant. Each warrant will entitle the holder to purchase one additional common share for a period of two years at an exercise price of 30 cents per share. The warrants will be subject to an accelerated expiration period in the event that the company's shares trade on a recognized exchange at more than 45 cents for a 14-day period, which will include days where no shares trade, after a period that is four months and a day from the issuance of the warrants.
The proceeds to be raised will be used for further exploration expenditures and for general working capital.
About Maxtech Ventures Inc.
Maxtech is a Canadian-based corporation with gold and manganese mineral properties.
Kootenay Zinc suspends E3 drilling at Sully
Kootenay Zinc Corp (C:ZNK)
Shares Issued 22,064,294
Last Close 7/20/2017 $0.09
Friday July 21 2017 - News Release
Mr. David Schmidt reports
SULLY PROJECT - E3 TARGET DRILLING UPDATE
Kootenay Zinc Corp.'s Sully project team has recently made two attempts to drill the E3 target from a location on the steep slope above and east of the target -- both holes experienced bad drilling conditions. Drilling was suspended before testing the zone to minimize the potential loss of equipment and to minimize costs. An alternative drill site has recently been identified and selected. It is near the valley bottom and provides an opportunity to drill E3 toward the east, roughly perpendicular to bedding and where surface outcrops indicate ground conditions will likely be more favorable.
Considerable infill gravity surveying has been done near the E3 anomaly. That work shows the anomaly appears to consist of several separate causes that mass modeling indicates have strike and depth dimensions of approximately 100 to 200 meters. Drilling should determine if these represent fault segments of a once continuous massive deposit. As described previously, drill testing will establish a 'proof of concept' and validity of the gravity geophysics technique in this area where work to date indicates several similar masses are likely present at each of E2, E4 and the West Target.
Results have been received from 88 soil samples collected on contour lines that cover the area from about the mid-point of the E3 and north through E4 gravity anomalies. This brings the total number of soil samples analyzed in 2017 to 120. Since the 1980s 873 soil samples have been analyzed for lead and zinc either by atomic absorption or, since 2000, by ion coupled plasma techniques. Several samples anomalous (mean plus two standard deviations of the 873 samples) in zinc are located along the trend or downslope of outlines of the 3 km-residual gravity anomalies E3 and E4. Other soil anomaly clusters up slope have not been covered by gravity surveying.
Newly mapped outcrops on the slope above and below (east and west) of the E3 area confirm structural trends previously documented. However, outcrops north and south of the E3 gravity anomaly area along the road used to access the E15/16 drill site are cut by numerous faults at differing orientations that are probably part of a narrow north trending zone that contributed to the drilling difficulties encountered.
Forest fire hazard conditions in the East Kootenays are now high, like that seen in other parts of the province and are not predicted to change in the next 30 days. Industrial activities (including the use of excavators and drills) are now restricted and will likely be banned by a closure order in the coming days. The drill was removed from the property and will be brought back when available and when forest fire risk is substantially lowered.
About Kootenay Zinc Corp.
Kootenay Zinc Corp. is a mineral exploration and development company based in Vancouver, British Columbia that is presently targeting the Sully Property. The Company is focused on discovering large-scale sedimentary-exhalative ("SEDEX") deposits.
The Sully Property comprises 1,375 hectares located approximately 30 kilometres east of Kimberley, B.C., and overlies rocks of similar age and origin as those which host the world-class Sullivan deposit, owned by Teck Resources Ltd. Sullivan was discovered in 1892, and is known to be one of the largest SEDEX deposits in the world. Over its 100-year lifetime, Sullivan produced approximately 150 million tons of ore, including approximately three hundred million ounces of silver, eight million tons of zinc and eight million tons of lead. The equivalent level of strata as at Sullivan and that formed on the margin of that same basin are present at the Sully Property. The Company cautions that past results or discoveries on proximate land are not necessarily indicative of the results that may be achieved on the Sully Property.
The scientific and technical information contained in this news release has been reviewed and approved by the Company's Project Manager, Paul Ransom, P.Geo., a "Qualified Person" as defined in National Instrument 43-101 - Standards of Disclosure for Mineral Projects.
We seek Safe Harbor.
3D Signatures Inc. Announces Short Form Prospectus Offering to Raise Up to C$5 Million
TORONTO, ONTARIO--(Marketwired - July 19, 2017) -
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
3D Signatures Inc. (TSX VENTURE:DXD)(OTCQB:TDSGF)(FRANKFURT:3D0) (the "Company" or "3DS") is pleased to announce that is has entered into an agreement with a syndicate of agents led by Haywood Securities Inc. ("Haywood"), as sole book-runner, and including Industrial Alliance Securities Inc. (collectively, the "Agents") to sell, by way of a short form prospectus, on a best efforts agency basis, up to 12,500,000 common shares in the capital of the Company (the "Common Shares") at a price of C$0.40 per Common Share (the "Offering Price"), for aggregate gross proceeds of up to C$5,000,000 (the "Offering"). In addition, the Company has granted to the Agents an option (the "Over-Allotment Option") to purchase up to an additional 1,875,000 Common Shares at the Offering Price, to cover over-allotments, if any. The Over-Allotment Option is exercisable by the Agents, in whole or in part, at any time up to 30 days following the closing date.
The Company has filed a preliminary short form prospectus dated July 18, 2017 (the "Preliminary Prospectus") with the securities regulatory authorities in the provinces of British Columbia, Alberta, Manitoba and Ontario pursuant to National Instrument 44-101 - Short Form Prospectus Distributions. The Common Shares will be offered for sale in the United States on a private placement basis pursuant to exemptions from the registration requirements of the United States Securities Act of 1933, as amended (the "U.S. Securities Act"). This press release is not an offer to sell, or a solicitation of an offer to buy, any of the securities in the United States. The Common Shares have not and will not be registered under the U.S. Securities Act or any U.S. state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from such registration. Subject to agreement between Haywood and the Company, each acting reasonably, the Common Shares may also be offered in other international jurisdictions pursuant to the appropriate exemptions and registration requirements in such jurisdictions.
In connection with the Offering, the Company has agreed to pay to the Agents a cash commission equal to 8.0% of the gross proceeds from the Offering, except in respect of any subscriptions by eligible purchasers under the Offering on a list provided by the Company and accepted by Haywood (the "President's List"), for which the Agents will only receive a cash commission equal to 2.0% of the gross proceeds from the Offering raised from such purchasers (the "Agents' Compensation"). The Company has also agreed to reimburse the Agents for reasonable expenses incurred in connection with the Offering, including the reasonable legal fees, up to a maximum amount of C$50,000 plus disbursements and taxes, of the Agents' legal counsel and reasonable out of pocket expenses, and will pay to the Haywood a corporate finance fee of C$40,000 plus tax (the "Corporate Finance Fee" and, together with the Agents' Compensation, the "Agents' Fee"). In addition to the the Agents' Fee, the Company has agreed to issue to the Agents broker warrants (the "Broker Warrants"), exercisable at the Offering Price to purchase such number of Common Shares as is equal to 8.0% of the aggregate number of Common Shares sold to purchasers not listed on the President's List, and 2.0% of the aggregate number of Common Shares sold to purchasers listed on the President's List. Each Broker Warrant shall be exercisable into one Common Share at any time prior to 5:00 p.m. (Vancouver time) on the date that is 24 months after the closing date.
In addition to the Agents' Fee and the Broker Warrants, the Company may be required to compensate certain finders (the "Finders") in relation to non-Canadian subscriptions secured by these Finders. To the extent that purchasers who have been introduced to the Company through these Finders participate in the Offering, cash commissions may be payable to these Finders and the Company may be required to issue to these Finders compensation warrants (the "Compensation Warrants"). In the case of any such subscriptions, the gross commissions payable to these Finders, including any Compensation Warrants issued to these Finders, shall not exceed the limitations set out in TSXV Policy 5.1 - Loans, Loan Bonuses, Finder's Fees and Commissions.
Subject to the amount of net proceeds ultimately received by the Company from the Offering, the Company intends that the net proceeds of the Offering in the following manner:
Hodgkin's Lymphoma - The Company plans to employ approximately 40% of the net proceeds from the Offering to complete the validation program for the Company's Telo-HL test and to commercially launch this test as a laboratory developed test.
Myeloma and Lung Cancer - The Company plans to employ approximately 20% of the net proceeds from the Offering to undertake pilot studies to determine the applicability of the Company's proprietary TeloView™ software platform to the lung cancer and myeloma diseases.
Clinical Wages and Laboratory Expenses and General Working Capital Expenditures - The Company will use approximately 40% of the net proceeds from the Offering to fund clinical wages and laboratory expenses related to the Company's ongoing research and development activities and for general working capital purposes.
For a complete description of the Company's anticipated uses for the proceeds from the Offering, potential investors should make reference to the Preliminary Prospectus.
Closing of the Offering is expected to occur on August 31, 2017 and is subject to certain conditions including, but not limited to, the receipt of all necessary approvals including the approval of the TSX Venture Exchange and the securities regulatory authorities.
About 3DS
3DS (TSX VENTURE:DXD)(OTCQB:TDSGF)(FRANKFURT:3D0) is a personalized medicine company with a proprietary software platform based on the three-dimensional analysis of chromosomal signatures. The technology is well developed and supported by 16 clinical studies on over 1,500 patients on 13 different cancers and Alzheimer's disease. Depending on the desired application, the technology can measure the stage of disease, the rate of progression of the disease, drug efficacy, and drug toxicity. The technology is designed to predict the course of the disease and to personalize treatment for the individual patient. For more information, visit the Company's new website at http://www.3dsignatures.com.
Cautionary Note Regarding Forward-Looking Statements
This news release contains forward looking statements which constitute "forward looking information" within the meaning of applicable Canadian securities legislation ("Forward Looking Statements"). All statements included herein, other than statements of historical fact, are Forward Looking Statements and are subject to a variety of known and unknown risks and uncertainties which could cause actual events or results to differ materially from those reflected in the Forward Looking Statements. The Forward Looking Statements in this news release include, without limitation, statements about the use of proceeds of the Offering, the expected closing date of the Offering, the ability to obtain the necessary approvals to complete the Offering and the compensation of the Agents and the Finders, including whether compensation will be payable to the Finders and the form and extent of any such compensation. Often, but not always, these Forward Looking Statements can be identified by the use of words such as "estimates", "potential", "open", "future", "assumes", "projects", "anticipates", "believes", "may", "continues", "expects", "plans", "will", "to be", or statements that events "could" or "should" occur or be achieved, and similar expressions, including negative variations.
Such Forward Looking Statements reflect the Company's current views with respect to future events are subject to risks and uncertainties and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by 3DS as of the date of such statements, are inherently subject to significant medical, scientific, business, economic, competitive, political and social uncertainties and contingencies. Many risk factors could cause the Company's actual results, performance, achievements, prospects or opportunities to be materially different from any future results, performance or achievements that may be expressed or implied by such Forward Looking Statements, including risks related to the volatility of the price of the Common Shares; risks related to the possibility that 3DS' shareholders may experience dilution; that 3DS' management will have discretion in the actual application of the net proceeds, and may elect to allocate proceeds differently from what is described herein; risks related to 3DS' requirements for additional financing and future access to capital, including the risk that the proceeds raised under the Offering may be insufficient to finance 3DS' business objectives; the risk that a positive return on an investment in the Common Shares is not guaranteed; risks related to 3DS' intention to retain earnings and not pay cash dividends on its Common Shares in the foreseeable future; risks related to 3DS' early stage of development; the risk that 3DS' tests will not be successfully deployed;
risks related to 3DS' dependence on third parties including collaborative partners, licensors and others; risks related to 3DS' clinical trial recruitment; uncertainties related to 3DS' clinical trials and test development; that there is currently no market for 3DS' products and that such market may be slow to develop if at all; risks related to 3DS' reliance on key personnel; risks related to the competitive nature of the biotechnology industry; risks related to 3DS' limited operating history, lack of revenue, history of losses and inability to assure that it will earn profits in the future or that profitability will be sustained; risks related to government regulation; risks related to rapid technological change; risks related to the fact that 3DS' software may now or in the future contain undetected errors, bugs or vulnerabilities; risks associated with 3DS' international operations; the risk that 3DS or its directors and officers may be subject to a variety of civil or other legal proceedings, with or without merit, including product liability claims; risks related to the protection of 3DS' intellectual property rights; risks related to 3DS' limited sales, marketing and distribution experience; risks related to the possibility that 3DS' directors and officers may be placed in a conflict of interest as a result of their employment or affiliation with third parties, risks related to 3DS' use and storage of personal information and compliance with applicable privacy laws, as well as those risks discussed under the heading "Risk Factors" in the Company's annual information form dated January 31, 2017 and filed on SEDAR, the Preliminary Prospectus and the Company's filing statement dated August 22, 2016 and filed on SEDAR. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in the Forward Looking Statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended.
In making the Forward Looking Statements, the Company has made various material assumptions including, but not limited to the timely receipt of regulatory and third party approvals related to the Offering; the completion of the Offering; obtaining positive results from 3DS' current and planned clinical trials; obtaining regulatory approvals with respect to 3DS' clinical trials which are now ongoing or may in the future be commenced; assumptions regarding general business and economic conditions; 3DS' ability to successfully develop its tests; 3DS' current positive relationship with third parties will be maintained; the availability of future financing on reasonable terms; 3DS' ability to attract and retain skilled staff; assumptions regarding market competition and the products and technology offered by 3DS' competitors; and 3DS' ability to protect patents and proprietary rights.
3DS believes that the assumptions and expectations reflected in the Forward Looking Statements in this press release are reasonable, but no assurance can be given that these expectations will prove to be correct. Forward Looking Statements should not be unduly relied upon. This information speaks only as of the date of this press release, and 3DS will not necessarily update this information, unless required to do so by securities laws.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Stephen Kilmer
Investor Relations
647-872-4849
stephen@kilmerlucas.com
Hugh Rogers
VP Corporate Finance
204-582-0922
investors@3dsignatures.com
Terry Bramhall
Investor Relations
1-604-428-8842
terry.bramhall@3dsignatures.com